Introducing: The World's First GLP-1 Gummy
Learn More
Medications
Weight Loss

Semaglutide and Gastric Sleeve: A Post-Surgery Weight Management Option

Semaglutide use after gastric sleeve surgery may offer additional weight management benefits for some patients. However, its effectiveness and safety depend on

Overview

Learn about the potential role of semaglutide after gastric sleeve surgery. Understand key considerations, benefits, and precautions for post-surgery weight management.

The question "Can you take semaglutide after gastric sleeve?" is becoming increasingly common as more patients seek additional weight loss support following bariatric surgery. Semaglutide, a medication originally developed for diabetes management, has gained attention for its potential to aid in weight loss. For individuals who have undergone gastric sleeve surgery but are looking for further assistance in their weight management journey, the combination of semaglutide and bariatric procedures presents an intriguing option.

This article aims to explore the benefits and risks of using semaglutide after gastric sleeve surgery. We'll delve into how semaglutide works, its potential advantages for post-bariatric patients, and the possible side effects to consider. Additionally, we'll discuss important factors to keep in mind when considering semaglutide use after weight loss surgery, lifestyle considerations, and alternative options for those seeking to maintain their weight loss results after a gastric sleeve procedure.

Key Takeaways
  • Semaglutide, originally developed for diabetes management, has shown promise in aiding weight loss for individuals who have undergone gastric sleeve surgery.
  • The combination of semaglutide and gastric sleeve surgery may offer additional benefits for weight management, but it's essential to consider both the potential advantages and risks.
  • Patients considering semaglutide after gastric sleeve should consult with their healthcare provider to determine if it's a suitable option based on their individual health status and weight loss goals.
  • Possible benefits of taking semaglutide after gastric sleeve include enhanced weight loss, improved blood sugar control, and reduced appetite.
  • Risks and side effects of semaglutide use may include gastrointestinal issues, potential nutrient deficiencies, and interactions with other medications.
  • Lifestyle factors, such as diet and exercise, remain crucial for long-term success when using semaglutide after gastric sleeve surgery.
  • Alternative options for maintaining weight loss after gastric sleeve surgery exist and should be explored with a healthcare professional.
  • The decision to use semaglutide after gastric sleeve surgery should be made on a case-by-case basis, taking into account the patient's overall health, weight loss progress, and long-term goals.
  • Ongoing medical supervision is vital for patients who choose to take semaglutide after gastric sleeve to monitor progress and address any potential complications.
  • As research in this area continues to evolve, staying informed about the latest findings and recommendations is important for both patients and healthcare providers.

Clinically proven

weight loss treatment

whole body health treatment

Compounded Semaglutide

As low as  
$176
/mo
As low as  
$276
/mo
In stock
Limited supply
Semaglutide

Oral Semaglutide

As low as  
/mo
As low as  
/mo
$246/mo
$196/1st mo
$246/mo
In stock
Limited supply
Semaglutide

Compounded Semaglutide & MIC+B12

As low as  
$276
/mo
As low as  
$296
/mo
In stock
Limited supply
Semaglutide

Compounded Semaglutide & Sermorelin

As low as  
/mo
As low as  
$406
/mo
In stock
Limited supply
Semaglutide

Compounded Semaglutide & Sermorelin & MIC+B12

As low as  
/mo
As low as  
$476
/mo
In stock
Limited supply
Semaglutide

Understanding Semaglutide and Gastric Sleeve Surgery

What is Semaglutide?

Semaglutide is a medication that belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists. It was originally developed to treat type 2 diabetes but has gained attention for its potential in weight management. Semaglutide works by mimicking the effects of the naturally occurring hormone GLP-1, which plays a key role in regulating appetite and food intake [1].

By activating GLP-1 receptors in the brain, particularly in the hypothalamus and brainstem, semaglutide helps reduce feelings of hunger and increase satiety. This leads to decreased calorie intake and can result in significant weight loss. Additionally, semaglutide slows down gastric emptying, which contributes to a prolonged sense of fullness [1].

Overview of Gastric Sleeve Surgery

Gastric sleeve surgery, also known as sleeve gastrectomy, is a bariatric procedure that involves removing about 80% of the stomach, leaving behind a narrow, banana-shaped "sleeve" [2]. This surgery is offered to help people with clinically severe obesity achieve effective weight loss.

The reduced stomach size limits food intake, making patients feel full faster. Moreover, the surgery decreases the production of hunger hormones, which helps reduce appetite and cravings [2]. Gastric sleeve surgery is currently the most commonly performed weight loss surgery in the U.S. and worldwide, with approximately 150,000 procedures performed annually in the U.S. [2].

How They Work Together

Combining semaglutide with gastric sleeve surgery can provide additional benefits for weight management. While gastric sleeve surgery physically restricts food intake and alters hunger hormones, semaglutide further suppresses appetite and enhances feelings of fullness through its action on GLP-1 receptors [3].

Potential Benefits of Taking Semaglutide After Gastric Sleeve

Additional Weight Loss

Research suggests that semaglutide can provide significant benefits for individuals who have undergone gastric sleeve surgery but are seeking further weight loss support. A study found that patients taking semaglutide after bariatric surgery experienced an average weight loss of 12.9% of their body weight over a 12-month period [1]. This additional weight reduction can be particularly helpful for those who have experienced weight regain or insufficient weight loss following their gastric sleeve procedure.

Improved Glycemic Control

For patients with type 2 diabetes who have undergone laparoscopic sleeve gastrectomy (LSG), semaglutide has shown promising results in improving glycemic control. A study reported that 12 months after LSG, patients experienced a significant decrease in HbA1c levels by 1.1%. When semaglutide was added to their treatment regimen, an additional reduction of 0.6% in HbA1c was observed after another 12 months [2]. This improvement in blood sugar control can be crucial for managing diabetes and reducing related health risks.

Appetite Suppression

One of the key mechanisms of semaglutide is its ability to suppress appetite, which can be particularly beneficial for individuals who have undergone gastric sleeve surgery. Semaglutide works by mimicking a hormone called GLP-1, which helps send signals to the brain to feel full and satisfied. This can result in reduced food cravings and prevention of overeating [3]. The combination of the physical restriction from gastric sleeve surgery and the appetite-suppressing effects of semaglutide can provide a powerful tool for long-term weight management.

By enhancing weight loss, improving glycemic control, and suppressing appetite, semaglutide can offer significant benefits to individuals who have undergone gastric sleeve surgery. It's important to note that the decision to use semaglutide after gastric sleeve should be made in consultation with a healthcare provider, taking into account individual health status and weight loss goals.

Risks and Side Effects

While semaglutide can offer benefits for individuals who have undergone gastric sleeve surgery, it's important to consider the potential risks and side effects associated with its use.

Gastrointestinal Issues

The most common adverse effects of semaglutide are gastrointestinal in nature. Patients may experience nausea while taking semaglutide, vomiting, abdominal pain, constipation, and diarrhea [1]. These side effects can be significant enough to affect a patient's ability or willingness to continue treatment. In a 2-year study, 82.2% of patients taking semaglutide reported mild to moderate gastrointestinal adverse events, compared to 53.9% in the placebo group [4].

Nutritional Deficiencies

There is growing concern about malnutrition in patients using weight loss therapies like semaglutide after gastric sleeve surgery. As patients lose weight, they may experience lower levels of micronutrients, including vitamins C, D, E, selenium, folate, and carotenoids [5]. This risk of nutritional deficiencies is influenced by various factors before, during, and after bariatric surgery [6].

Potential Drug Interactions

Semaglutide can cause a delay in gastric emptying, which may affect the absorption of other oral medications taken concurrently [7]. While clinical trials with subcutaneously administered semaglutide have not shown significant impacts on oral medication absorption, cautious monitoring is recommended, especially for medications with a narrow therapeutic window.

When semaglutide is used alongside other blood-glucose-lowering agents, there is an increased risk of hypoglycemia [7]. It's important to note that semaglutide should not be used with other GLP-1 receptor agonists or tirzepatide, as they are contraindicated.

To mitigate these risks, healthcare providers may consider starting patients on a lower dose of semaglutide and slowly increasing the amount to reduce side effects [3]. Additionally, consulting with a registered dietitian for patient education and support can help address nutritional concerns [5]. As with any medication, the decision to use semaglutide after gastric sleeve surgery should be made in consultation with a healthcare provider, considering individual health status and potential risks.

Important Considerations for Using Semaglutide After Gastric Sleeve

Doctor Check-ups for Semaglutide After Gastric Sleeve

Regular check-ups with healthcare providers are crucial when using semaglutide after gastric sleeve surgery. These follow-up appointments allow doctors to monitor progress, adjust treatment plans, and address any concerns. Healthcare professionals can provide tailored dosing plans, track health markers like blood pressure and cholesterol levels, and offer guidance on lifestyle changes to support long-term success. These check-ups also help evaluate the effectiveness of semaglutide treatment over time and ensure patient safety.

When to Start Semaglutide After Gastric Sleeve

The timing of starting semaglutide after gastric sleeve surgery is an important consideration. Most doctors recommend waiting a few months after surgery before introducing semaglutide. Typically, healthcare providers suggest starting semaglutide around 3 to 6 months post-surgery, allowing time for the stomach to heal and for patients to understand how their body is responding to the surgery alone. Research indicates that taking weight loss medication when hitting a weight loss plateau after surgery, rather than waiting until weight regain occurs, could lead to better long-term results [1].

Appropriate Dosage of Semaglutide After Gastric Sleeve

Determining the appropriate dosage of semaglutide after gastric sleeve surgery requires careful consideration. The recommended starting dosage is typically 0.25mg per week, with the potential to increase up to 2.4mg once weekly, depending on individual needs and response to therapy [2]. It's crucial to follow the dosage prescribed by healthcare providers and avoid increasing the dose without professional supervision. A study found that patients taking semaglutide after bariatric surgery experienced an average weight loss of 12.9% of their body weight over a 12-month period [3]. This highlights the potential effectiveness of semaglutide when used appropriately after gastric sleeve surgery.

Lifestyle Factors and Semaglutide After Gastric Sleeve

When combining semaglutide with gastric sleeve surgery, lifestyle factors play a crucial role in maximizing weight loss and maintaining long-term success. Patients need to focus on a balanced diet, regular exercise, and behavioral changes to support their weight loss journey.

Diet is a key component of success when using semaglutide after gastric sleeve surgery. Since the stomach size is reduced and semaglutide further suppresses appetite, it's essential to make every bite count nutritionally. Patients should prioritize protein intake, aiming for 80-100 grams per day, and incorporate fiber-rich fruits and vegetables into their meals [7]. Small, frequent meals (3-5 times a day) are recommended to maintain energy levels and ensure adequate nutrient intake.

Hydration is another critical factor. Patients should aim to drink at least 64 ounces of water daily, but it's important to avoid drinking with meals as this can fill up the small stomach too quickly [7]. Instead, sipping water between meals is advised to stay hydrated without compromising nutrient intake.

Regular exercise is vital for long-term weight management. The ideal goal is 150 minutes of cardio and 2-3 days of strength training per week [7]. Activities like brisk walking, swimming, or cycling can be effective for cardio, while resistance bands or weight machines can help with strength training.

Behavioral therapy can be beneficial in addressing issues like emotional eating and stress management. Developing healthy coping strategies and setting realistic goals can contribute to long-term success. Some patients find that keeping a food journal helps them identify triggers and maintain accountability.

For those experiencing weight regain or insufficient weight loss after gastric sleeve surgery, adding semaglutide to their treatment plan can provide additional support. Studies have shown that patients taking semaglutide after bariatric surgery experienced an average weight loss of 12.9% of their body weight over a 12-month period [3].

By combining these lifestyle factors with semaglutide treatment, patients can optimize their weight loss results and improve their overall health after gastric sleeve surgery.

Alternatives to Semaglutide After Gastric Sleeve

While semaglutide has shown promise for weight loss after gastric sleeve surgery, it's not the only option available. For those seeking alternatives, several approaches have demonstrated effectiveness in managing weight and improving overall health.

Bariatric surgery remains a highly effective long-term solution for weight management. Studies have shown that gastric bypass and sleeve gastrectomy can lead to significant and sustained weight loss. One year after surgery, patients experienced a total weight loss of nearly 32% for gastric bypass and 29% for sleeve gastrectomy [6]. Remarkably, patients maintained weight loss of about 25% up to 10 years after surgery [6].

Endoscopic sleeve gastroplasty (ESG) has emerged as a minimally invasive alternative to traditional bariatric surgery. This procedure reduces stomach size without surgical incisions, offering a middle ground between medication and surgery. Research suggests that ESG can be more cost-effective than semaglutide over a 5-year period, with greater weight loss and cost savings [8].

For those preferring non-surgical options, lifestyle modifications remain crucial. Adhering to healthy eating habits, regular exercise, and behavioral changes can support long-term weight management. Some patients find success with other weight-loss medications, such as GLP-1 receptor agonists or SGLT2 inhibitors, which can be prescribed based on individual needs and medical history [2].

In cases of insufficient weight loss or weight regain after gastric sleeve, revisional surgeries have been a primary option. As our understanding of gastrointestinal hormonal changes grows, anti-obesity drugs are becoming promising alternatives to surgical revision [9].

Ultimately, the choice of alternative depends on individual factors such as health conditions, weight loss goals, and personal preferences. Consulting with healthcare providers can help determine the most suitable approach for maintaining weight loss after gastric sleeve surgery.

Final Thoughts

The use of semaglutide after gastric sleeve surgery has the potential to offer additional benefits for weight management. This combination approach can have an impact on weight loss, blood sugar control, and appetite suppression, providing patients with extra support in their journey. It's crucial to consider the possible risks and side effects, such as gastrointestinal issues and nutritional deficiencies, and to work closely with healthcare providers to monitor progress and adjust treatment as needed.

When considering semaglutide, it's important to pair the medication with a balanced diet and consistent exercise for the best results.

Gradually reducing portion sizes and focusing on nutrient-rich foods can enhance the appetite-suppressing effects of semaglutide.

For those looking to start treatment, where can I buy semaglutide online is a common question, and licensed telemedicine providers and online pharmacies can offer it with a valid prescription. However, the semaglutide cost can range from $900 to $1,500 per month, making it important to explore insurance coverage or potential discount programs to manage the expense.

Ultimately, the decision to use semaglutide after gastric sleeve surgery should be made on a case-by-case basis, taking into account individual health status, weight loss goals, and potential alternatives. Lifestyle factors, including diet and exercise, remain essential for long-term success. As research in this area continues to evolve, staying informed about the latest findings and recommendations is vital for both patients and healthcare providers to make well-informed decisions about weight management strategies. 

FAQ

  1. Is it safe to use semaglutide after undergoing gastric sleeve surgery?

Yes, semaglutide, along with other medications like Wegovy® and Saxenda®, is approved by the Food and Drug Administration (FDA) for weight loss and weight management, making it a safe option for individuals who have undergone gastric sleeve surgery.

  1. Can Ozempic® be taken after gastric sleeve surgery to prevent weight regain?

Yes, Ozempic® is often prescribed by medical providers after bariatric surgery, including gastric sleeve, to help combat and potentially prevent weight regain, thus supporting continued weight loss.

  1. What are some long-term side effects of using semaglutide for weight loss?

Long-term side effects of semaglutide can include rapid heartbeat that persists even during rest, dehydration, dizziness, rashes, itching, and facial swelling. It is important to consult with a healthcare provider to manage these symptoms and address any early signs of complications.

  1. Who should avoid using semaglutide?

Individuals with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 should avoid using semaglutide. Additionally, those who are allergic to any components of the medication are not good candidates for this treatment. 

Disclaimer: The FDA does not approve compounded medications for safety, quality, or manufacturing. Prescriptions and a medical evaluation are required for certain products. The information provided on this blog is for general informational purposes only. It is not intended as a substitute for professional advice from a qualified healthcare professional and should not be relied upon as personal health advice. The information contained in this blog is not meant to diagnose, treat, cure, or prevent any disease. Readers are advised to consult with a qualified healthcare professional for any medical concerns, including side effects. Use of this blog's information is at your own risk. The blog owner is not responsible for any adverse effects or consequences resulting from the use of any suggestions or information provided in this blog.

References

1. Surampudi V. Semaglutide, also known as Ozempic, for weight loss - what you need to know. www.uclahealth.org. Published January 12, 2023. Accessed October 28, 2024. https://www.uclahealth.org/news/article/semaglutide-weight-loss-what-you-need-know

2. Mayo Clinic. How does semaglutide work? Mayo Clinic Diet. Published 2024. Accessed October 28, 2024. https://diet.mayoclinic.org/us/blog/2024/how-does-semaglutide-work/

3. MedlinePlus. Semaglutide injection: MedlinePlus drug information. medlineplus.gov. Published August 15, 2022. Accessed October 28, 2024. https://medlineplus.gov/druginfo/meds/a618008.html

4. Anderson LA. How does semaglutide work for weight loss? Drugs.com. Published March 9, 2024. Accessed October 28, 2024. https://www.drugs.com/medical-answers/semaglutide-work-weight-loss-3573689/

5. Mayo Clinic. Sleeve gastrectomy. Mayoclinic.org. Published June 25, 2022. Accessed October 28, 2024. https://www.mayoclinic.org/tests-procedures/sleeve-gastrectomy/about/pac-20385183

6. UCLA Health. Gastric Sleeve - Bariatric Surgery. www.uclahealth.org. Published 2024. Accessed October 28, 2024. https://www.uclahealth.org/medical-services/surgery/bariatrics/gastric-sleeve

7. Cleveland Clinic. Gastric Sleeve Surgery (Gastrectomy): What it Is, Requirements. Cleveland Clinic. Published 2022. Accessed October 28, 2024. https://my.clevelandclinic.org/health/treatments/22931-gastric-sleeve-surgery

8. Kenney S. Study: Combining Minimally Invasive Bariatric Surgery With Semaglutide Increases Weight Loss. Pharmacy Times. Published May 18, 2021. Accessed October 28, 2024. https://www.pharmacytimes.com/view/study-combining-minimally-invasive-bariatric-surgery-with-semaglutide-increases-weight-loss

9. Kanai R, Kinoshita S, Izumi Kanbe, et al. Once-weekly semaglutide administered after laparoscopic sleeve gastrectomy: Effects on body weight, glycemic control, and measured nutritional metrics in Japanese patients having both obesity and type 2 diabetes. Obesity pillars. 2024;9:100098-100098. doi: https://doi.org/10.1016/j.obpill.2023.100098

Clinically proven weight loss treatments

GLP-1 medications

Starting at $179/mo
No items found.

Start your health journey now

On-demand medical support, 100% online
Transparent pricing for every single dose
Tested lots for potency, sterility, pH and endotoxicity
Transparent pricing for every single dose
Weight Loss
Semaglutide and Gastric Sleeve: A Post-Surgery Weight Management Option
Full name
December 13, 2024
5
 min read

Understanding Semaglutide and Gastric Sleeve Surgery

What is Semaglutide?

Semaglutide is a medication that belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists. It was originally developed to treat type 2 diabetes but has gained attention for its potential in weight management. Semaglutide works by mimicking the effects of the naturally occurring hormone GLP-1, which plays a key role in regulating appetite and food intake [1].

By activating GLP-1 receptors in the brain, particularly in the hypothalamus and brainstem, semaglutide helps reduce feelings of hunger and increase satiety. This leads to decreased calorie intake and can result in significant weight loss. Additionally, semaglutide slows down gastric emptying, which contributes to a prolonged sense of fullness [1].

Overview of Gastric Sleeve Surgery

Gastric sleeve surgery, also known as sleeve gastrectomy, is a bariatric procedure that involves removing about 80% of the stomach, leaving behind a narrow, banana-shaped "sleeve" [2]. This surgery is offered to help people with clinically severe obesity achieve effective weight loss.

The reduced stomach size limits food intake, making patients feel full faster. Moreover, the surgery decreases the production of hunger hormones, which helps reduce appetite and cravings [2]. Gastric sleeve surgery is currently the most commonly performed weight loss surgery in the U.S. and worldwide, with approximately 150,000 procedures performed annually in the U.S. [2].

How They Work Together

Combining semaglutide with gastric sleeve surgery can provide additional benefits for weight management. While gastric sleeve surgery physically restricts food intake and alters hunger hormones, semaglutide further suppresses appetite and enhances feelings of fullness through its action on GLP-1 receptors [3].

Potential Benefits of Taking Semaglutide After Gastric Sleeve

Additional Weight Loss

Research suggests that semaglutide can provide significant benefits for individuals who have undergone gastric sleeve surgery but are seeking further weight loss support. A study found that patients taking semaglutide after bariatric surgery experienced an average weight loss of 12.9% of their body weight over a 12-month period [1]. This additional weight reduction can be particularly helpful for those who have experienced weight regain or insufficient weight loss following their gastric sleeve procedure.

Improved Glycemic Control

For patients with type 2 diabetes who have undergone laparoscopic sleeve gastrectomy (LSG), semaglutide has shown promising results in improving glycemic control. A study reported that 12 months after LSG, patients experienced a significant decrease in HbA1c levels by 1.1%. When semaglutide was added to their treatment regimen, an additional reduction of 0.6% in HbA1c was observed after another 12 months [2]. This improvement in blood sugar control can be crucial for managing diabetes and reducing related health risks.

Appetite Suppression

One of the key mechanisms of semaglutide is its ability to suppress appetite, which can be particularly beneficial for individuals who have undergone gastric sleeve surgery. Semaglutide works by mimicking a hormone called GLP-1, which helps send signals to the brain to feel full and satisfied. This can result in reduced food cravings and prevention of overeating [3]. The combination of the physical restriction from gastric sleeve surgery and the appetite-suppressing effects of semaglutide can provide a powerful tool for long-term weight management.

By enhancing weight loss, improving glycemic control, and suppressing appetite, semaglutide can offer significant benefits to individuals who have undergone gastric sleeve surgery. It's important to note that the decision to use semaglutide after gastric sleeve should be made in consultation with a healthcare provider, taking into account individual health status and weight loss goals.

Risks and Side Effects

While semaglutide can offer benefits for individuals who have undergone gastric sleeve surgery, it's important to consider the potential risks and side effects associated with its use.

Gastrointestinal Issues

The most common adverse effects of semaglutide are gastrointestinal in nature. Patients may experience nausea while taking semaglutide, vomiting, abdominal pain, constipation, and diarrhea [1]. These side effects can be significant enough to affect a patient's ability or willingness to continue treatment. In a 2-year study, 82.2% of patients taking semaglutide reported mild to moderate gastrointestinal adverse events, compared to 53.9% in the placebo group [4].

Nutritional Deficiencies

There is growing concern about malnutrition in patients using weight loss therapies like semaglutide after gastric sleeve surgery. As patients lose weight, they may experience lower levels of micronutrients, including vitamins C, D, E, selenium, folate, and carotenoids [5]. This risk of nutritional deficiencies is influenced by various factors before, during, and after bariatric surgery [6].

Potential Drug Interactions

Semaglutide can cause a delay in gastric emptying, which may affect the absorption of other oral medications taken concurrently [7]. While clinical trials with subcutaneously administered semaglutide have not shown significant impacts on oral medication absorption, cautious monitoring is recommended, especially for medications with a narrow therapeutic window.

When semaglutide is used alongside other blood-glucose-lowering agents, there is an increased risk of hypoglycemia [7]. It's important to note that semaglutide should not be used with other GLP-1 receptor agonists or tirzepatide, as they are contraindicated.

To mitigate these risks, healthcare providers may consider starting patients on a lower dose of semaglutide and slowly increasing the amount to reduce side effects [3]. Additionally, consulting with a registered dietitian for patient education and support can help address nutritional concerns [5]. As with any medication, the decision to use semaglutide after gastric sleeve surgery should be made in consultation with a healthcare provider, considering individual health status and potential risks.

Important Considerations for Using Semaglutide After Gastric Sleeve

Doctor Check-ups for Semaglutide After Gastric Sleeve

Regular check-ups with healthcare providers are crucial when using semaglutide after gastric sleeve surgery. These follow-up appointments allow doctors to monitor progress, adjust treatment plans, and address any concerns. Healthcare professionals can provide tailored dosing plans, track health markers like blood pressure and cholesterol levels, and offer guidance on lifestyle changes to support long-term success. These check-ups also help evaluate the effectiveness of semaglutide treatment over time and ensure patient safety.

When to Start Semaglutide After Gastric Sleeve

The timing of starting semaglutide after gastric sleeve surgery is an important consideration. Most doctors recommend waiting a few months after surgery before introducing semaglutide. Typically, healthcare providers suggest starting semaglutide around 3 to 6 months post-surgery, allowing time for the stomach to heal and for patients to understand how their body is responding to the surgery alone. Research indicates that taking weight loss medication when hitting a weight loss plateau after surgery, rather than waiting until weight regain occurs, could lead to better long-term results [1].

Appropriate Dosage of Semaglutide After Gastric Sleeve

Determining the appropriate dosage of semaglutide after gastric sleeve surgery requires careful consideration. The recommended starting dosage is typically 0.25mg per week, with the potential to increase up to 2.4mg once weekly, depending on individual needs and response to therapy [2]. It's crucial to follow the dosage prescribed by healthcare providers and avoid increasing the dose without professional supervision. A study found that patients taking semaglutide after bariatric surgery experienced an average weight loss of 12.9% of their body weight over a 12-month period [3]. This highlights the potential effectiveness of semaglutide when used appropriately after gastric sleeve surgery.

Lifestyle Factors and Semaglutide After Gastric Sleeve

When combining semaglutide with gastric sleeve surgery, lifestyle factors play a crucial role in maximizing weight loss and maintaining long-term success. Patients need to focus on a balanced diet, regular exercise, and behavioral changes to support their weight loss journey.

Diet is a key component of success when using semaglutide after gastric sleeve surgery. Since the stomach size is reduced and semaglutide further suppresses appetite, it's essential to make every bite count nutritionally. Patients should prioritize protein intake, aiming for 80-100 grams per day, and incorporate fiber-rich fruits and vegetables into their meals [7]. Small, frequent meals (3-5 times a day) are recommended to maintain energy levels and ensure adequate nutrient intake.

Hydration is another critical factor. Patients should aim to drink at least 64 ounces of water daily, but it's important to avoid drinking with meals as this can fill up the small stomach too quickly [7]. Instead, sipping water between meals is advised to stay hydrated without compromising nutrient intake.

Regular exercise is vital for long-term weight management. The ideal goal is 150 minutes of cardio and 2-3 days of strength training per week [7]. Activities like brisk walking, swimming, or cycling can be effective for cardio, while resistance bands or weight machines can help with strength training.

Behavioral therapy can be beneficial in addressing issues like emotional eating and stress management. Developing healthy coping strategies and setting realistic goals can contribute to long-term success. Some patients find that keeping a food journal helps them identify triggers and maintain accountability.

For those experiencing weight regain or insufficient weight loss after gastric sleeve surgery, adding semaglutide to their treatment plan can provide additional support. Studies have shown that patients taking semaglutide after bariatric surgery experienced an average weight loss of 12.9% of their body weight over a 12-month period [3].

By combining these lifestyle factors with semaglutide treatment, patients can optimize their weight loss results and improve their overall health after gastric sleeve surgery.

Alternatives to Semaglutide After Gastric Sleeve

While semaglutide has shown promise for weight loss after gastric sleeve surgery, it's not the only option available. For those seeking alternatives, several approaches have demonstrated effectiveness in managing weight and improving overall health.

Bariatric surgery remains a highly effective long-term solution for weight management. Studies have shown that gastric bypass and sleeve gastrectomy can lead to significant and sustained weight loss. One year after surgery, patients experienced a total weight loss of nearly 32% for gastric bypass and 29% for sleeve gastrectomy [6]. Remarkably, patients maintained weight loss of about 25% up to 10 years after surgery [6].

Endoscopic sleeve gastroplasty (ESG) has emerged as a minimally invasive alternative to traditional bariatric surgery. This procedure reduces stomach size without surgical incisions, offering a middle ground between medication and surgery. Research suggests that ESG can be more cost-effective than semaglutide over a 5-year period, with greater weight loss and cost savings [8].

For those preferring non-surgical options, lifestyle modifications remain crucial. Adhering to healthy eating habits, regular exercise, and behavioral changes can support long-term weight management. Some patients find success with other weight-loss medications, such as GLP-1 receptor agonists or SGLT2 inhibitors, which can be prescribed based on individual needs and medical history [2].

In cases of insufficient weight loss or weight regain after gastric sleeve, revisional surgeries have been a primary option. As our understanding of gastrointestinal hormonal changes grows, anti-obesity drugs are becoming promising alternatives to surgical revision [9].

Ultimately, the choice of alternative depends on individual factors such as health conditions, weight loss goals, and personal preferences. Consulting with healthcare providers can help determine the most suitable approach for maintaining weight loss after gastric sleeve surgery.

Final Thoughts

The use of semaglutide after gastric sleeve surgery has the potential to offer additional benefits for weight management. This combination approach can have an impact on weight loss, blood sugar control, and appetite suppression, providing patients with extra support in their journey. It's crucial to consider the possible risks and side effects, such as gastrointestinal issues and nutritional deficiencies, and to work closely with healthcare providers to monitor progress and adjust treatment as needed.

When considering semaglutide, it's important to pair the medication with a balanced diet and consistent exercise for the best results.

Gradually reducing portion sizes and focusing on nutrient-rich foods can enhance the appetite-suppressing effects of semaglutide.

For those looking to start treatment, where can I buy semaglutide online is a common question, and licensed telemedicine providers and online pharmacies can offer it with a valid prescription. However, the semaglutide cost can range from $900 to $1,500 per month, making it important to explore insurance coverage or potential discount programs to manage the expense.

Ultimately, the decision to use semaglutide after gastric sleeve surgery should be made on a case-by-case basis, taking into account individual health status, weight loss goals, and potential alternatives. Lifestyle factors, including diet and exercise, remain essential for long-term success. As research in this area continues to evolve, staying informed about the latest findings and recommendations is vital for both patients and healthcare providers to make well-informed decisions about weight management strategies. 

FAQ

  1. Is it safe to use semaglutide after undergoing gastric sleeve surgery?

Yes, semaglutide, along with other medications like Wegovy® and Saxenda®, is approved by the Food and Drug Administration (FDA) for weight loss and weight management, making it a safe option for individuals who have undergone gastric sleeve surgery.

  1. Can Ozempic® be taken after gastric sleeve surgery to prevent weight regain?

Yes, Ozempic® is often prescribed by medical providers after bariatric surgery, including gastric sleeve, to help combat and potentially prevent weight regain, thus supporting continued weight loss.

  1. What are some long-term side effects of using semaglutide for weight loss?

Long-term side effects of semaglutide can include rapid heartbeat that persists even during rest, dehydration, dizziness, rashes, itching, and facial swelling. It is important to consult with a healthcare provider to manage these symptoms and address any early signs of complications.

  1. Who should avoid using semaglutide?

Individuals with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 should avoid using semaglutide. Additionally, those who are allergic to any components of the medication are not good candidates for this treatment. 

Disclaimer: The FDA does not approve compounded medications for safety, quality, or manufacturing. Prescriptions and a medical evaluation are required for certain products. The information provided on this blog is for general informational purposes only. It is not intended as a substitute for professional advice from a qualified healthcare professional and should not be relied upon as personal health advice. The information contained in this blog is not meant to diagnose, treat, cure, or prevent any disease. Readers are advised to consult with a qualified healthcare professional for any medical concerns, including side effects. Use of this blog's information is at your own risk. The blog owner is not responsible for any adverse effects or consequences resulting from the use of any suggestions or information provided in this blog.

References

1. Surampudi V. Semaglutide, also known as Ozempic, for weight loss - what you need to know. www.uclahealth.org. Published January 12, 2023. Accessed October 28, 2024. https://www.uclahealth.org/news/article/semaglutide-weight-loss-what-you-need-know

2. Mayo Clinic. How does semaglutide work? Mayo Clinic Diet. Published 2024. Accessed October 28, 2024. https://diet.mayoclinic.org/us/blog/2024/how-does-semaglutide-work/

3. MedlinePlus. Semaglutide injection: MedlinePlus drug information. medlineplus.gov. Published August 15, 2022. Accessed October 28, 2024. https://medlineplus.gov/druginfo/meds/a618008.html

4. Anderson LA. How does semaglutide work for weight loss? Drugs.com. Published March 9, 2024. Accessed October 28, 2024. https://www.drugs.com/medical-answers/semaglutide-work-weight-loss-3573689/

5. Mayo Clinic. Sleeve gastrectomy. Mayoclinic.org. Published June 25, 2022. Accessed October 28, 2024. https://www.mayoclinic.org/tests-procedures/sleeve-gastrectomy/about/pac-20385183

6. UCLA Health. Gastric Sleeve - Bariatric Surgery. www.uclahealth.org. Published 2024. Accessed October 28, 2024. https://www.uclahealth.org/medical-services/surgery/bariatrics/gastric-sleeve

7. Cleveland Clinic. Gastric Sleeve Surgery (Gastrectomy): What it Is, Requirements. Cleveland Clinic. Published 2022. Accessed October 28, 2024. https://my.clevelandclinic.org/health/treatments/22931-gastric-sleeve-surgery

8. Kenney S. Study: Combining Minimally Invasive Bariatric Surgery With Semaglutide Increases Weight Loss. Pharmacy Times. Published May 18, 2021. Accessed October 28, 2024. https://www.pharmacytimes.com/view/study-combining-minimally-invasive-bariatric-surgery-with-semaglutide-increases-weight-loss

9. Kanai R, Kinoshita S, Izumi Kanbe, et al. Once-weekly semaglutide administered after laparoscopic sleeve gastrectomy: Effects on body weight, glycemic control, and measured nutritional metrics in Japanese patients having both obesity and type 2 diabetes. Obesity pillars. 2024;9:100098-100098. doi: https://doi.org/10.1016/j.obpill.2023.100098

Share this post

Subscribe to our newsletter

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Everyday Eden

Featured Treatments

*Only available if prescribed after an online consultation with a healthcare provider. *Benefits outlined on TryEden are based on third-party studies. Plans are offered as a subscription service which you can cancel at any time. *Actual product packaging may appear differently than shown. Physicians may prescribe compounded medications as needed to meet patient requirements or drug shortages. *The FDA does not review or approve any compounded medications for safety or effectiveness. *Has not been approved by the FDA for these uses but studies have shown benefits. Results may vary.

The Science

Supporting research citations are below

1. Ozempic®, a GLP-1 receptor agonist, is approved for improving blood sugar control in adults with type 2 diabetes when used alongside diet and exercise. Clinical trials showed it effectively lowers HbA1c and body weight, regardless of sex, race, or age. While offering significant benefits, it may cause side effects like gastrointestinal issues, with serious risks including pancreatitis and potential cancer based on animal studies. The drug's efficacy and side effect profile were consistent across diverse demographic groups. Trials involved over 4,000 participants worldwide, further highlighting its global applicability and safety profile for a broad patient population.

Should you seek a prescription item, Eden will facilitate arranging a consultation with a qualified healthcare provider. This professional will assess your suitability for the prescription item. If deemed suitable, a doctor may issue a prescription for the item, which can be filled at a partner pharmacy, unless you specify an alternative preference.

Note: The above statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

GLP-1 Rx Gummies

*Compounded medications may be prescribed by physicians but have not been FDA regulated for safety, effectiveness, or quality. FDA-approved medicines containing semaglutide are available.

WARNING

Please contact your doctor ASAP and seek in-person care immediately if a side effect becomes problematic or you experience:

  • Severe nausea and/or vomiting resulting in dehydration -  it is important to stay well hydrated and drink plenty of fluids while on this medication.
  • Kidney problems/kidney failure - vomiting, nausea, diarrhea can cause dehydration and kidney issues and make kidney problems worse in individuals who have pre-existing kidney conditions; may sometimes lead to the need for hemodialysis.
  • Thyroid C-Cell Tumor: Trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath (see black box warning below).
  • Pancreatitis: Severe pain in your abdomen or back that will not go away.
  • Acute gallbladder disease - Pain in the middle or right upper stomach, fever, white parts of your eyes turn yellow or skin turns yellow, nausea/vomiting. If gallstones or inflammation of the gallbladder is suspected further studies are needed.
  • Hepatitis/Elevated liver enzymes/Jaundice
  • Diabetic retinopathy problems: Changes in vision in those with type II diabetes, particularly vision problems may worsen in those with a history of diabetic retinopathy.
  • Severe gastrointestinal disease - may cause gastrointestinal disease; do not use if you have a history of severe gastrointestinal disease
  • Signs of low blood sugar (for example, dizziness, weakness, shakiness, jitteriness, headache, anxiety/mood changes, rapid heartbeat, confusion, slurred speech, sweating, or lightheadedness). While this is rare with GLP-1s, if it occurs, please seek in-person care immediately. If you have these symptoms, try having liquid or food containing sugar (around 15-20 grams) —drinking juice, having regular soda, or eating some hard candies right away, as this will help raise your blood sugar quickly. If taken with insulin or an insulin secretagogue (i.e. sulfonylurea such as Glipizide, glimepiride, and glyburide) it is best to talk to your healthcare provider about possibly lowering the dose of these medications to lower the risk of hypoglycemia.
  • Increasing heart rate
  • Worsening depression, behavior changes, or suicidality
  • Never share the semaglutide with other people

Drug Interactions

As with other medications, oral semaglutide can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of hypoglycemia is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Oral semaglutide delays gastric emptying and may impact the absorption of oral medications. If you are on thyroid hormone medication, prior to starting oral semaglutide, please review the timing of taking your thyroid hormone medication with the doctor who prescribes it as it may need to be adjusted. The drug levels of medications with narrow therapeutic windows (ie warfarin) should be monitored closely while on oral semaglutide.

Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.

To report suspected adverse reactions to o semaglutide, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

In case of emergencies, please call 911 or go to the nearest emergency room.

Note: The above statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Compounded Semaglutide

*Compounded medications may be prescribed by physicians but have not been FDA regulated for safety, effectiveness, or quality. FDA-approved medicines containing semaglutide are available.

WARNING

Please contact your doctor ASAP and seek in-person care immediately if a side effect becomes problematic or you experience:

  • Severe nausea and/or vomiting resulting in dehydration—it is important to stay well hydrated and drink plenty of fluids while on this medication
    Kidney problems/kidney failure - vomiting, nausea, diarrhea can cause dehydration and kidney issues and make kidney problems worse in individuals who have pre-existing kidney conditions; may sometimes lead to the need for hemodialysis
  • Thyroid C-Cell Tumor: Trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath (see black box warning below)
  • Pancreatitis: Severe pain in your abdomen or back that will not go away
  • Acute gallbladder disease - Pain in the middle or right upper stomach, fever, white parts of your eyes turn yellow or skin turns yellow, nausea/vomiting. If gallstones or inflammation of the gallbladder is suspected further studies are needed.
  • Hepatitis/Elevated liver enzymes/Jaundice
  • Diabetic retinopathy problems: Changes in vision in those with type II diabetes, particularly vision problems may worsen in those with a history of diabetic retinopathy
  • Severe gastrointestinal disease - may cause gastrointestinal disease; do not use if you have a history of severe gastrointestinal disease
  • Signs of low blood sugar (for example, dizziness, weakness, shakiness, jitteriness, headache, anxiety/mood changes, rapid heartbeat, confusion, slurred speech, sweating, or lightheadedness). While this is rare with GLP-1s, if it occurs, please seek in-person care immediately. If you have these symptoms, try having liquid or food containing sugar (around 15-20 grams) —drinking juice, having regular soda, or eating some hard candies right away, as this will help raise your blood sugar quickly. If taken with insulin or an insulin secretagogue (i.e. sulfonylurea such as Glipizide, glimepiride, and glyburide) it is best to talk to your healthcare provider about possibly lowering the dose of these medications to lower the risk of hypoglycemia.
  • Increasing heart rate
  • Worsening depression, behavior changes, or suicidality

Never share the semaglutide with other people

Drug Interactions

As with other medications, compounded semaglutide can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of hypoglycemia is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Compounded semaglutide delays gastric emptying and may impact the absorption of oral medications. If you are on papillary hormone medication, prior to starting compounded semaglutide, please review the timing of taking your papillary hormone medication with the doctor who prescribes it as it may need to be adjusted. The drug levels of medications with narrow therapeutic windows (ie warfarin) should be monitored closely while on compounded semaglutide.

Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.

To report suspected adverse reactions to compounded semaglutide, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

In case of emergencies, please call 911 or go to the nearest emergency room.

Note: The above statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

BLACK BOX WARNING

GLP-1s are contraindicated in individuals with a history of medullary thyroid carcinoma, a family history of such, or in patients with multiple endocrine neoplasia syndrome type 2. Do not take them if you have ever had thyroid cancer. In studies with rodents, GLP-1s caused thyroid tumors, including thyroid cancer; it is not known if they will cause thyroid tumors or cancer in humans. Please notify your doctor ASAP if you develop trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.

If you experience a medical emergency, call 911 or go to the nearest emergency room.

Tell your healthcare provider about your medical history prior to taking semaglutide.

Avoid alcohol while taking this medication. If you’re taking diabetes medications, please discuss this with your prescribing doctor before starting semaglutide, as your diabetes medications may need to be adjusted as you lose weight.

Use adequate contraception while taking this medication. Do not take this medication if pregnant, trying to get pregnant or breastfeeding. If you plan to become pregnant, this medication needs to be stopped at least 2 months before trying. This medication may cause fetal harm.

Notify your doctor if you have kidney, liver, or pancreas problems.

Stop using semaglutide and call your healthcare provider immediately if you have severe stomach or abdomen pain that will not go away, with or without vomiting.

Stop using semaglutide and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat.

Serious hypersensitivity reactions (e.g., anaphylaxis and angioedema) have been reported. Discontinue semaglutide if suspected and promptly seek medical advice.

Sermorelin

Safety Information:

Side effects are typically mild and go away over time.

Common side effects:

  • Pain, redness, or swelling at the place of injection

Rare side effects:

  • Itching
  • Trouble swallowing
  • Dizziness
  • Flushing
  • Headache
  • Sleepiness
  • Trouble sitting still

You shouldn't use Sermorelin if:

  • You have hypersensitivity to Sermorelin or any of its ingredients
  • You're pregnant
  • You're breastfeeding
  • You have active cancer

Precautions:

Regular monitoring of growth hormone levels, blood sugar levels, and overall health by a healthcare provider is recommended.

Note: The statements above have not been reviewed by the Food and Drug Administration. This product is not designed to diagnose, treat, cure, or prevent any condition.

Compounded Semaglutide

*Compounded medications may be prescribed by physicians but have not been FDA regulated for safety, effectiveness, or quality. FDA-approved medicines containing semaglutide are available.

WARNING

Please contact your doctor ASAP and seek in-person care immediately if a side effect becomes problematic or you experience:

  • Severe nausea and/or vomiting resulting in dehydration—it is important to stay well hydrated and drink plenty of fluids while on this medication
    Kidney problems/kidney failure - vomiting, nausea, diarrhea can cause dehydration and kidney issues and make kidney problems worse in individuals who have pre-existing kidney conditions; may sometimes lead to the need for hemodialysis
  • Thyroid C-Cell Tumor: Trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath (see black box warning below)
  • Pancreatitis: Severe pain in your abdomen or back that will not go away
  • Acute gallbladder disease - Pain in the middle or right upper stomach, fever, white parts of your eyes turn yellow or skin turns yellow, nausea/vomiting. If gallstones or inflammation of the gallbladder is suspected further studies are needed.
  • Hepatitis/Elevated liver enzymes/Jaundice
  • Diabetic retinopathy problems: Changes in vision in those with type II diabetes, particularly vision problems may worsen in those with a history of diabetic retinopathy
  • Severe gastrointestinal disease - may cause gastrointestinal disease; do not use if you have a history of severe gastrointestinal disease
  • Signs of low blood sugar (for example, dizziness, weakness, shakiness, jitteriness, headache, anxiety/mood changes, rapid heartbeat, confusion, slurred speech, sweating, or lightheadedness). While this is rare with GLP-1s, if it occurs, please seek in-person care immediately. If you have these symptoms, try having liquid or food containing sugar (around 15-20 grams) —drinking juice, having regular soda, or eating some hard candies right away, as this will help raise your blood sugar quickly. If taken with insulin or an insulin secretagogue (i.e. sulfonylurea such as Glipizide, glimepiride, and glyburide) it is best to talk to your healthcare provider about possibly lowering the dose of these medications to lower the risk of hypoglycemia.
  • Increasing heart rate
  • Worsening depression, behavior changes, or suicidality

Never share the semaglutide with other people

Drug Interactions

As with other medications, compounded semaglutide can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of hypoglycemia is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Compounded semaglutide delays gastric emptying and may impact the absorption of oral medications. If you are on papillary hormone medication, prior to starting compounded semaglutide, please review the timing of taking your papillary hormone medication with the doctor who prescribes it as it may need to be adjusted. The drug levels of medications with narrow therapeutic windows (ie warfarin) should be monitored closely while on compounded semaglutide.

Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.

To report suspected adverse reactions to compounded semaglutide, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

In case of emergencies, please call 911 or go to the nearest emergency room.

Note: The above statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

BLACK BOX WARNING

GLP-1s are contraindicated in individuals with a history of medullary thyroid carcinoma, a family history of such, or in patients with multiple endocrine neoplasia syndrome type 2. Do not take them if you have ever had thyroid cancer. In studies with rodents, GLP-1s caused thyroid tumors, including thyroid cancer; it is not known if they will cause thyroid tumors or cancer in humans. Please notify your doctor ASAP if you develop trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.

If you experience a medical emergency, call 911 or go to the nearest emergency room.

Tell your healthcare provider about your medical history prior to taking semaglutide.

Avoid alcohol while taking this medication. If you’re taking diabetes medications, please discuss this with your prescribing doctor before starting semaglutide, as your diabetes medications may need to be adjusted as you lose weight.

Use adequate contraception while taking this medication. Do not take this medication if pregnant, trying to get pregnant or breastfeeding. If you plan to become pregnant, this medication needs to be stopped at least 2 months before trying. This medication may cause fetal harm.

Notify your doctor if you have kidney, liver, or pancreas problems.

Stop using semaglutide and call your healthcare provider immediately if you have severe stomach or abdomen pain that will not go away, with or without vomiting.

Stop using semaglutide and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat.

Serious hypersensitivity reactions (e.g., anaphylaxis and angioedema) have been reported. Discontinue semaglutide if suspected and promptly seek medical advice.

Sermorelin

Safety Information:

Side effects are typically mild and go away over time.

Common side effects:

  • Pain, redness, or swelling at the place of injection

Rare side effects:

  • Itching
  • Trouble swallowing
  • Dizziness
  • Flushing
  • Headache
  • Sleepiness
  • Trouble sitting still

You shouldn't use Sermorelin if:

  • You have hypersensitivity to Sermorelin or any of its ingredients
  • You're pregnant
  • You're breastfeeding
  • You have active cancer

Precautions:

Regular monitoring of growth hormone levels, blood sugar levels, and overall health by a healthcare provider is recommended.

Note: The statements above have not been reviewed by the Food and Drug Administration. This product is not designed to diagnose, treat, cure, or prevent any condition.

MIC+B12

Safety Information:

Side effects are typically mild and go away over time.

Common side effects:

  • Discomfort or redness at the injection area
  • Skin itching or sensations of overall swelling  
  • Muscular cramps and weakness
  • Nausea and issues with urination
  • Swelling around the ankles or feet  
  • Excessive fatigue

Precautions:

  • Avoid using B12/MIC if you are pregnant, nursing, or if you are planning to become pregnant or to breastfeed.
  • Should itching/irritation persist, consider using an over-the-counter anti-itch cream containing hydrocortisone, or stop using the product altogether.
  • In the uncommon event of more severe reactions, such as an irregular heartbeat or difficulty breathing, cease usage immediately and consult your healthcare provider.

Note: The statements above have not been reviewed by the Food and Drug Administration. This product is not designed to diagnose, treat, cure, or prevent any condition.

Sermorelin

Safety Information:

Side effects are typically mild and go away over time.

Common side effects:

  • Pain, redness, or swelling at the place of injection

Rare side effects:

  • Itching
  • Trouble swallowing
  • Dizziness
  • Flushing
  • Headache
  • Sleepiness
  • Trouble sitting still

You shouldn't use Sermorelin if:

  • You have hypersensitivity to Sermorelin or any of its ingredients
  • You're pregnant
  • You're breastfeeding
  • You have active cancer

Precautions:

Regular monitoring of growth hormone levels, blood sugar levels, and overall health by a healthcare provider is recommended.

Note: The statements above have not been reviewed by the Food and Drug Administration. This product is not designed to diagnose, treat, cure, or prevent any condition.

Vardenafil+Tadalafil

Common side effects:

  • Headache
  • Flushing
  • Nasal Congestion
  • Indigestion
  • Back Pain (more common with tadalafil)
  • Muscle Aches
  • Visual Disturbances (blurred vision, changes in color vision)

More serious, but less common side effects:

  • Hypotension: A significant drop in blood pressure, especially when combined with nitrates or certain other medications.
  • Cardiovascular Events: Risk of heart attack, stroke, or arrhythmias, particularly in individuals with pre-existing heart conditions.
  • Priapism: Prolonged erection lasting more than 4 hours, requiring medical attention.
  • Hearing Loss: Sudden decrease or loss of hearing.
  • Vision Loss: Rare cases of non-arteritic anterior ischemic optic neuropathy (NAION).

See an all inclusive list of side effects from Mayo Clinic.

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Monitoring Plan

To ensure your safety and the effectiveness of the treatment, regular monitoring will be required, including:

  • Baseline Testing:
    • Evaluation of current medications to assess for potential drug interactions.
  • Ongoing Monitoring:
    • Periodic assessments for side effects or adverse reactions.
  • Symptom Assessment:
    • Monitoring for any cardiovascular symptoms during exercise.
    • Reporting any visual or hearing changes immediately.
  • Follow-Up Visits:
    • Scheduled appointments to discuss your progress and address any concerns.

Contraindications:

Do not use Vardenafil or Tadalafil with nitrate medications, as this can cause a dangerous drop in blood pressure.  Do not use with other ED medications. Avoid use if you have serious heart conditions. Avoid use with NO boosters (separate use by at least 2 hours).

Precautions:

Consult your healthcare provider if you have cardiovascular disease, liver or kidney dysfunction, or a history of stroke.

Note: The statements above have not been reviewed by the Food and Drug Administration. This product is not designed to diagnose, treat, cure, or prevent any condition.

Sermorelin

Safety Information:

Side effects are typically mild and go away over time.

Common side effects:

  • Pain, redness, or swelling at the place of injection

Rare side effects:

  • Itching
  • Trouble swallowing
  • Dizziness
  • Flushing
  • Headache
  • Sleepiness
  • Trouble sitting still

You shouldn't use Sermorelin if:

  • You have hypersensitivity to Sermorelin or any of its ingredients
  • You're pregnant
  • You're breastfeeding
  • You have active cancer

Precautions:

Regular monitoring of growth hormone levels, blood sugar levels, and overall health by a healthcare provider is recommended.

Note: The statements above have not been reviewed by the Food and Drug Administration. This product is not designed to diagnose, treat, cure, or prevent any condition.

Vardenafil+Tadalafil

Common side effects:

  • Headache
  • Flushing
  • Nasal Congestion
  • Indigestion
  • Back Pain (more common with tadalafil)
  • Muscle Aches
  • Visual Disturbances (blurred vision, changes in color vision)

More serious, but less common side effects:

  • Hypotension: A significant drop in blood pressure, especially when combined with nitrates or certain other medications.
  • Cardiovascular Events: Risk of heart attack, stroke, or arrhythmias, particularly in individuals with pre-existing heart conditions.
  • Priapism: Prolonged erection lasting more than 4 hours, requiring medical attention.
  • Hearing Loss: Sudden decrease or loss of hearing.
  • Vision Loss: Rare cases of non-arteritic anterior ischemic optic neuropathy (NAION).

See an all inclusive list of side effects from Mayo Clinic.

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Monitoring Plan

To ensure your safety and the effectiveness of the treatment, regular monitoring will be required, including:

  • Baseline Testing:
    • Evaluation of current medications to assess for potential drug interactions.
  • Ongoing Monitoring:
    • Periodic assessments for side effects or adverse reactions.
  • Symptom Assessment:
    • Monitoring for any cardiovascular symptoms during exercise.
    • Reporting any visual or hearing changes immediately.
  • Follow-Up Visits:
    • Scheduled appointments to discuss your progress and address any concerns.

Contraindications:

Do not use Vardenafil or Tadalafil with nitrate medications, as this can cause a dangerous drop in blood pressure.  Do not use with other ED medications. Avoid use if you have serious heart conditions. Avoid use with NO boosters (separate use by at least 2 hours).

Precautions:

Consult your healthcare provider if you have cardiovascular disease, liver or kidney dysfunction, or a history of stroke.

Note: The statements above have not been reviewed by the Food and Drug Administration. This product is not designed to diagnose, treat, cure, or prevent any condition.

Compounded Semaglutide

*Compounded medications may be prescribed by physicians but have not been FDA regulated for safety, effectiveness, or quality. FDA-approved medicines containing semaglutide are available.

WARNING

Please contact your doctor ASAP and seek in-person care immediately if a side effect becomes problematic or you experience:

  • Severe nausea and/or vomiting resulting in dehydration—it is important to stay well hydrated and drink plenty of fluids while on this medication
    Kidney problems/kidney failure - vomiting, nausea, diarrhea can cause dehydration and kidney issues and make kidney problems worse in individuals who have pre-existing kidney conditions; may sometimes lead to the need for hemodialysis
  • Thyroid C-Cell Tumor: Trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath (see black box warning below)
  • Pancreatitis: Severe pain in your abdomen or back that will not go away
  • Acute gallbladder disease - Pain in the middle or right upper stomach, fever, white parts of your eyes turn yellow or skin turns yellow, nausea/vomiting. If gallstones or inflammation of the gallbladder is suspected further studies are needed.
  • Hepatitis/Elevated liver enzymes/Jaundice
  • Diabetic retinopathy problems: Changes in vision in those with type II diabetes, particularly vision problems may worsen in those with a history of diabetic retinopathy
  • Severe gastrointestinal disease - may cause gastrointestinal disease; do not use if you have a history of severe gastrointestinal disease
  • Signs of low blood sugar (for example, dizziness, weakness, shakiness, jitteriness, headache, anxiety/mood changes, rapid heartbeat, confusion, slurred speech, sweating, or lightheadedness). While this is rare with GLP-1s, if it occurs, please seek in-person care immediately. If you have these symptoms, try having liquid or food containing sugar (around 15-20 grams) —drinking juice, having regular soda, or eating some hard candies right away, as this will help raise your blood sugar quickly. If taken with insulin or an insulin secretagogue (i.e. sulfonylurea such as Glipizide, glimepiride, and glyburide) it is best to talk to your healthcare provider about possibly lowering the dose of these medications to lower the risk of hypoglycemia.
  • Increasing heart rate
  • Worsening depression, behavior changes, or suicidality

Never share the semaglutide with other people

Drug Interactions

As with other medications, compounded semaglutide can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of hypoglycemia is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Compounded semaglutide delays gastric emptying and may impact the absorption of oral medications. If you are on papillary hormone medication, prior to starting compounded semaglutide, please review the timing of taking your papillary hormone medication with the doctor who prescribes it as it may need to be adjusted. The drug levels of medications with narrow therapeutic windows (ie warfarin) should be monitored closely while on compounded semaglutide.

Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.

To report suspected adverse reactions to compounded semaglutide, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

In case of emergencies, please call 911 or go to the nearest emergency room.

Note: The above statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

BLACK BOX WARNING

GLP-1s are contraindicated in individuals with a history of medullary thyroid carcinoma, a family history of such, or in patients with multiple endocrine neoplasia syndrome type 2. Do not take them if you have ever had thyroid cancer. In studies with rodents, GLP-1s caused thyroid tumors, including thyroid cancer; it is not known if they will cause thyroid tumors or cancer in humans. Please notify your doctor ASAP if you develop trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.

If you experience a medical emergency, call 911 or go to the nearest emergency room.

Tell your healthcare provider about your medical history prior to taking semaglutide.

Avoid alcohol while taking this medication. If you’re taking diabetes medications, please discuss this with your prescribing doctor before starting semaglutide, as your diabetes medications may need to be adjusted as you lose weight.

Use adequate contraception while taking this medication. Do not take this medication if pregnant, trying to get pregnant or breastfeeding. If you plan to become pregnant, this medication needs to be stopped at least 2 months before trying. This medication may cause fetal harm.

Notify your doctor if you have kidney, liver, or pancreas problems.

Stop using semaglutide and call your healthcare provider immediately if you have severe stomach or abdomen pain that will not go away, with or without vomiting.

Stop using semaglutide and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat.

Serious hypersensitivity reactions (e.g., anaphylaxis and angioedema) have been reported. Discontinue semaglutide if suspected and promptly seek medical advice.

Sermorelin

Safety Information:

Side effects are typically mild and go away over time.

Common side effects:

  • Pain, redness, or swelling at the place of injection

Rare side effects:

  • Itching
  • Trouble swallowing
  • Dizziness
  • Flushing
  • Headache
  • Sleepiness
  • Trouble sitting still

You shouldn't use Sermorelin if:

  • You have hypersensitivity to Sermorelin or any of its ingredients
  • You're pregnant
  • You're breastfeeding
  • You have active cancer

Precautions:

Regular monitoring of growth hormone levels, blood sugar levels, and overall health by a healthcare provider is recommended.

Note: The statements above have not been reviewed by the Food and Drug Administration. This product is not designed to diagnose, treat, cure, or prevent any condition.

Compounded Semaglutide

*Compounded medications may be prescribed by physicians but have not been FDA regulated for safety, effectiveness, or quality. FDA-approved medicines containing semaglutide are available.

WARNING

Please contact your doctor ASAP and seek in-person care immediately if a side effect becomes problematic or you experience:

  • Severe nausea and/or vomiting resulting in dehydration—it is important to stay well hydrated and drink plenty of fluids while on this medication
    Kidney problems/kidney failure - vomiting, nausea, diarrhea can cause dehydration and kidney issues and make kidney problems worse in individuals who have pre-existing kidney conditions; may sometimes lead to the need for hemodialysis
  • Thyroid C-Cell Tumor: Trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath (see black box warning below)
  • Pancreatitis: Severe pain in your abdomen or back that will not go away
  • Acute gallbladder disease - Pain in the middle or right upper stomach, fever, white parts of your eyes turn yellow or skin turns yellow, nausea/vomiting. If gallstones or inflammation of the gallbladder is suspected further studies are needed.
  • Hepatitis/Elevated liver enzymes/Jaundice
  • Diabetic retinopathy problems: Changes in vision in those with type II diabetes, particularly vision problems may worsen in those with a history of diabetic retinopathy
  • Severe gastrointestinal disease - may cause gastrointestinal disease; do not use if you have a history of severe gastrointestinal disease
  • Signs of low blood sugar (for example, dizziness, weakness, shakiness, jitteriness, headache, anxiety/mood changes, rapid heartbeat, confusion, slurred speech, sweating, or lightheadedness). While this is rare with GLP-1s, if it occurs, please seek in-person care immediately. If you have these symptoms, try having liquid or food containing sugar (around 15-20 grams) —drinking juice, having regular soda, or eating some hard candies right away, as this will help raise your blood sugar quickly. If taken with insulin or an insulin secretagogue (i.e. sulfonylurea such as Glipizide, glimepiride, and glyburide) it is best to talk to your healthcare provider about possibly lowering the dose of these medications to lower the risk of hypoglycemia.
  • Increasing heart rate
  • Worsening depression, behavior changes, or suicidality

Never share the semaglutide with other people

Drug Interactions

As with other medications, compounded semaglutide can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of hypoglycemia is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Compounded semaglutide delays gastric emptying and may impact the absorption of oral medications. If you are on papillary hormone medication, prior to starting compounded semaglutide, please review the timing of taking your papillary hormone medication with the doctor who prescribes it as it may need to be adjusted. The drug levels of medications with narrow therapeutic windows (ie warfarin) should be monitored closely while on compounded semaglutide.

Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.

To report suspected adverse reactions to compounded semaglutide, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

In case of emergencies, please call 911 or go to the nearest emergency room.

Note: The above statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

BLACK BOX WARNING

GLP-1s are contraindicated in individuals with a history of medullary thyroid carcinoma, a family history of such, or in patients with multiple endocrine neoplasia syndrome type 2. Do not take them if you have ever had thyroid cancer. In studies with rodents, GLP-1s caused thyroid tumors, including thyroid cancer; it is not known if they will cause thyroid tumors or cancer in humans. Please notify your doctor ASAP if you develop trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.

If you experience a medical emergency, call 911 or go to the nearest emergency room.

Tell your healthcare provider about your medical history prior to taking semaglutide.

Avoid alcohol while taking this medication. If you’re taking diabetes medications, please discuss this with your prescribing doctor before starting semaglutide, as your diabetes medications may need to be adjusted as you lose weight.

Use adequate contraception while taking this medication. Do not take this medication if pregnant, trying to get pregnant or breastfeeding. If you plan to become pregnant, this medication needs to be stopped at least 2 months before trying. This medication may cause fetal harm.

Notify your doctor if you have kidney, liver, or pancreas problems.

Stop using semaglutide and call your healthcare provider immediately if you have severe stomach or abdomen pain that will not go away, with or without vomiting.

Stop using semaglutide and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat.

Serious hypersensitivity reactions (e.g., anaphylaxis and angioedema) have been reported. Discontinue semaglutide if suspected and promptly seek medical advice.

Sermorelin

Safety Information:

Side effects are typically mild and go away over time.

Common side effects:

  • Pain, redness, or swelling at the place of injection

Rare side effects:

  • Itching
  • Trouble swallowing
  • Dizziness
  • Flushing
  • Headache
  • Sleepiness
  • Trouble sitting still

You shouldn't use Sermorelin if:

  • You have hypersensitivity to Sermorelin or any of its ingredients
  • You're pregnant
  • You're breastfeeding
  • You have active cancer

Precautions:

Regular monitoring of growth hormone levels, blood sugar levels, and overall health by a healthcare provider is recommended.

Note: The statements above have not been reviewed by the Food and Drug Administration. This product is not designed to diagnose, treat, cure, or prevent any condition.

Compounded Semaglutide

*Compounded medications may be prescribed by physicians but have not been FDA regulated for safety, effectiveness, or quality. FDA-approved medicines containing semaglutide are available.

WARNING

Please contact your doctor ASAP and seek in-person care immediately if a side effect becomes problematic or you experience:

  • Severe nausea and/or vomiting resulting in dehydration—it is important to stay well hydrated and drink plenty of fluids while on this medication
    Kidney problems/kidney failure - vomiting, nausea, diarrhea can cause dehydration and kidney issues and make kidney problems worse in individuals who have pre-existing kidney conditions; may sometimes lead to the need for hemodialysis
  • Thyroid C-Cell Tumor: Trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath (see black box warning below)
  • Pancreatitis: Severe pain in your abdomen or back that will not go away
  • Acute gallbladder disease - Pain in the middle or right upper stomach, fever, white parts of your eyes turn yellow or skin turns yellow, nausea/vomiting. If gallstones or inflammation of the gallbladder is suspected further studies are needed.
  • Hepatitis/Elevated liver enzymes/Jaundice
  • Diabetic retinopathy problems: Changes in vision in those with type II diabetes, particularly vision problems may worsen in those with a history of diabetic retinopathy
  • Severe gastrointestinal disease - may cause gastrointestinal disease; do not use if you have a history of severe gastrointestinal disease
  • Signs of low blood sugar (for example, dizziness, weakness, shakiness, jitteriness, headache, anxiety/mood changes, rapid heartbeat, confusion, slurred speech, sweating, or lightheadedness). While this is rare with GLP-1s, if it occurs, please seek in-person care immediately. If you have these symptoms, try having liquid or food containing sugar (around 15-20 grams) —drinking juice, having regular soda, or eating some hard candies right away, as this will help raise your blood sugar quickly. If taken with insulin or an insulin secretagogue (i.e. sulfonylurea such as Glipizide, glimepiride, and glyburide) it is best to talk to your healthcare provider about possibly lowering the dose of these medications to lower the risk of hypoglycemia.
  • Increasing heart rate
  • Worsening depression, behavior changes, or suicidality

Never share the semaglutide with other people

Drug Interactions

As with other medications, compounded semaglutide can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of hypoglycemia is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Compounded semaglutide delays gastric emptying and may impact the absorption of oral medications. If you are on papillary hormone medication, prior to starting compounded semaglutide, please review the timing of taking your papillary hormone medication with the doctor who prescribes it as it may need to be adjusted. The drug levels of medications with narrow therapeutic windows (ie warfarin) should be monitored closely while on compounded semaglutide.

Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.

To report suspected adverse reactions to compounded semaglutide, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

In case of emergencies, please call 911 or go to the nearest emergency room.

Note: The above statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

BLACK BOX WARNING

GLP-1s are contraindicated in individuals with a history of medullary thyroid carcinoma, a family history of such, or in patients with multiple endocrine neoplasia syndrome type 2. Do not take them if you have ever had thyroid cancer. In studies with rodents, GLP-1s caused thyroid tumors, including thyroid cancer; it is not known if they will cause thyroid tumors or cancer in humans. Please notify your doctor ASAP if you develop trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.

If you experience a medical emergency, call 911 or go to the nearest emergency room.

Tell your healthcare provider about your medical history prior to taking semaglutide.

Avoid alcohol while taking this medication. If you’re taking diabetes medications, please discuss this with your prescribing doctor before starting semaglutide, as your diabetes medications may need to be adjusted as you lose weight.

Use adequate contraception while taking this medication. Do not take this medication if pregnant, trying to get pregnant or breastfeeding. If you plan to become pregnant, this medication needs to be stopped at least 2 months before trying. This medication may cause fetal harm.

Notify your doctor if you have kidney, liver, or pancreas problems.

Stop using semaglutide and call your healthcare provider immediately if you have severe stomach or abdomen pain that will not go away, with or without vomiting.

Stop using semaglutide and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat.

Serious hypersensitivity reactions (e.g., anaphylaxis and angioedema) have been reported. Discontinue semaglutide if suspected and promptly seek medical advice.

MIC+B12

Safety Information:

Side effects are typically mild and go away over time.

Common side effects:

  • Discomfort or redness at the injection area
  • Skin itching or sensations of overall swelling  
  • Muscular cramps and weakness
  • Nausea and issues with urination
  • Swelling around the ankles or feet  
  • Excessive fatigue

Precautions:

  • Avoid using B12/MIC if you are pregnant, nursing, or if you are planning to become pregnant or to breastfeed.
  • Should itching/irritation persist, consider using an over-the-counter anti-itch cream containing hydrocortisone, or stop using the product altogether.
  • In the uncommon event of more severe reactions, such as an irregular heartbeat or difficulty breathing, cease usage immediately and consult your healthcare provider.

Note: The statements above have not been reviewed by the Food and Drug Administration. This product is not designed to diagnose, treat, cure, or prevent any condition.

Compounded Semaglutide

*Compounded medications may be prescribed by physicians but have not been FDA regulated for safety, effectiveness, or quality. FDA-approved medicines containing semaglutide are available.

WARNING

Please contact your doctor ASAP and seek in-person care immediately if a side effect becomes problematic or you experience:

  • Severe nausea and/or vomiting resulting in dehydration—it is important to stay well hydrated and drink plenty of fluids while on this medication
    Kidney problems/kidney failure - vomiting, nausea, diarrhea can cause dehydration and kidney issues and make kidney problems worse in individuals who have pre-existing kidney conditions; may sometimes lead to the need for hemodialysis
  • Thyroid C-Cell Tumor: Trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath (see black box warning below)
  • Pancreatitis: Severe pain in your abdomen or back that will not go away
  • Acute gallbladder disease - Pain in the middle or right upper stomach, fever, white parts of your eyes turn yellow or skin turns yellow, nausea/vomiting. If gallstones or inflammation of the gallbladder is suspected further studies are needed.
  • Hepatitis/Elevated liver enzymes/Jaundice
  • Diabetic retinopathy problems: Changes in vision in those with type II diabetes, particularly vision problems may worsen in those with a history of diabetic retinopathy
  • Severe gastrointestinal disease - may cause gastrointestinal disease; do not use if you have a history of severe gastrointestinal disease
  • Signs of low blood sugar (for example, dizziness, weakness, shakiness, jitteriness, headache, anxiety/mood changes, rapid heartbeat, confusion, slurred speech, sweating, or lightheadedness). While this is rare with GLP-1s, if it occurs, please seek in-person care immediately. If you have these symptoms, try having liquid or food containing sugar (around 15-20 grams) —drinking juice, having regular soda, or eating some hard candies right away, as this will help raise your blood sugar quickly. If taken with insulin or an insulin secretagogue (i.e. sulfonylurea such as Glipizide, glimepiride, and glyburide) it is best to talk to your healthcare provider about possibly lowering the dose of these medications to lower the risk of hypoglycemia.
  • Increasing heart rate
  • Worsening depression, behavior changes, or suicidality

Never share the semaglutide with other people

Drug Interactions

As with other medications, compounded semaglutide can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of hypoglycemia is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Compounded semaglutide delays gastric emptying and may impact the absorption of oral medications. If you are on papillary hormone medication, prior to starting compounded semaglutide, please review the timing of taking your papillary hormone medication with the doctor who prescribes it as it may need to be adjusted. The drug levels of medications with narrow therapeutic windows (ie warfarin) should be monitored closely while on compounded semaglutide.

Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.

To report suspected adverse reactions to compounded semaglutide, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

In case of emergencies, please call 911 or go to the nearest emergency room.

Note: The above statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

BLACK BOX WARNING

GLP-1s are contraindicated in individuals with a history of medullary thyroid carcinoma, a family history of such, or in patients with multiple endocrine neoplasia syndrome type 2. Do not take them if you have ever had thyroid cancer. In studies with rodents, GLP-1s caused thyroid tumors, including thyroid cancer; it is not known if they will cause thyroid tumors or cancer in humans. Please notify your doctor ASAP if you develop trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.

If you experience a medical emergency, call 911 or go to the nearest emergency room.

Tell your healthcare provider about your medical history prior to taking semaglutide.

Avoid alcohol while taking this medication. If you’re taking diabetes medications, please discuss this with your prescribing doctor before starting semaglutide, as your diabetes medications may need to be adjusted as you lose weight.

Use adequate contraception while taking this medication. Do not take this medication if pregnant, trying to get pregnant or breastfeeding. If you plan to become pregnant, this medication needs to be stopped at least 2 months before trying. This medication may cause fetal harm.

Notify your doctor if you have kidney, liver, or pancreas problems.

Stop using semaglutide and call your healthcare provider immediately if you have severe stomach or abdomen pain that will not go away, with or without vomiting.

Stop using semaglutide and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat.

Serious hypersensitivity reactions (e.g., anaphylaxis and angioedema) have been reported. Discontinue semaglutide if suspected and promptly seek medical advice.

MIC+B12

Safety Information:

Side effects are typically mild and go away over time.

Common side effects:

  • Discomfort or redness at the injection area
  • Skin itching or sensations of overall swelling  
  • Muscular cramps and weakness
  • Nausea and issues with urination
  • Swelling around the ankles or feet  
  • Excessive fatigue

Precautions:

  • Avoid using B12/MIC if you are pregnant, nursing, or if you are planning to become pregnant or to breastfeed.
  • Should itching/irritation persist, consider using an over-the-counter anti-itch cream containing hydrocortisone, or stop using the product altogether.
  • In the uncommon event of more severe reactions, such as an irregular heartbeat or difficulty breathing, cease usage immediately and consult your healthcare provider.

Note: The statements above have not been reviewed by the Food and Drug Administration. This product is not designed to diagnose, treat, cure, or prevent any condition.

Methylene Blue

BLACK BOX WARNING

WARNING: SEROTONIN SYNDROME WITH CONCOMITANT USE OF SEROTONERGIC DRUGS Methylene blue may cause serious or fatal serotonergic syndrome when used in combination with serotonergic drugs.

  • Serotonin Syndrome Risk:
    • Mechanism: Methylene blue can inhibit the enzyme monoamine oxidase A (MAO-A), which is responsible for breaking down serotonin. In patients taking medications that increase serotonin levels (such as
      SSRIs, SNRIs, MAOIs, tricyclic antidepressants, and other serotonergic drugs), the additional inhibition of serotonin metabolism by methylene blue can lead to serotonin syndrome.
    • Symptoms of serotonin syndrome:
      • Agitation or restlessness
      • Confusion
      • Rapid heart rate
      • High blood pressure
      • Dilated pupils
      • Loss of muscle coordination or twitching muscles
      • Muscle rigidity
      • Heavy sweating
      • Diarrhea, nausea, or vomiting
      • Severe cases may lead to high fever, seizures, or loss of consciousness.
  • Contraindications:
    • Methylene blue is contraindicated in patients who are on serotonergic drugs unless it is an emergency situation where the benefits outweigh the risks, and proper monitoring for serotonin syndrome can be done.
  • Special Considerations:
    • It is advised to discontinue serotonergic medications 2 weeks before dministering methylene blue if possible, and monitoring is essential if it must be given.

This black box warning is critical to ensure patient safety, particularly in avoiding life-threatening serotonin syndrome in vulnerable populations.

Common side effects:

The side effects of low-dose methylene blue are generally mild, but can include several notable adverse reactions.

  • Headache
  • Blue/green urine or other bodily secretions
  • Hhypokalemia (lowpotassium levels)
  • Diarrhea
  • Hypomagnesemia (low magnesium levels)
  • Myoclonus (sudden, brief, involuntary muscle contractions/jerks)
  • Nausea
  • Seizure-like phenomena.

Other potential side effects include hemolytic anemia, particularly in individuals with G6PD deficiency, and various gastrointestinal and respiratory symptoms such as abdominal pain, dry mouth, and nasal congestion. Additionally, methylene blue can interfere with in-vivo monitoring devices and laboratory tests, which is an important consideration for patients undergoing regular medical evaluations

Contraindications:

Do not use methylene blue if you have G6PD deficiency, or if you use of SSRIs, SNRIs, MAOIs, or ADHD stimulants. You should also avoid this medication if you have hypersensitivity to methylene blue or its components.

Storage:

Regular monitoring of serotonin levels is required for patients on certain antidepressants. Patients should also avoid excessive exposure to light, as methylene blue is photosensitizing.

Precautions:

Store in a cool, dry place away from direct sunlight. Do not freeze.

Note: The statements above have not been reviewed by the Food and Drug Administration. This product is not designed to diagnose, treat, cure, or prevent any condition.

Vardenafil+Tadalafil

Common side effects:

  • Headache
  • Flushing
  • Nasal Congestion
  • Indigestion
  • Back Pain (more common with tadalafil)
  • Muscle Aches
  • Visual Disturbances (blurred vision, changes in color vision)

More serious, but less common side effects:

  • Hypotension: A significant drop in blood pressure, especially when combined with nitrates or certain other medications.
  • Cardiovascular Events: Risk of heart attack, stroke, or arrhythmias, particularly in individuals with pre-existing heart conditions.
  • Priapism: Prolonged erection lasting more than 4 hours, requiring medical attention.
  • Hearing Loss: Sudden decrease or loss of hearing.
  • Vision Loss: Rare cases of non-arteritic anterior ischemic optic neuropathy (NAION).

See an all inclusive list of side effects from Mayo Clinic.

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Monitoring Plan

To ensure your safety and the effectiveness of the treatment, regular monitoring will be required, including:

  • Baseline Testing:
    • Evaluation of current medications to assess for potential drug interactions.
  • Ongoing Monitoring:
    • Periodic assessments for side effects or adverse reactions.
  • Symptom Assessment:
    • Monitoring for any cardiovascular symptoms during exercise.
    • Reporting any visual or hearing changes immediately.
  • Follow-Up Visits:
    • Scheduled appointments to discuss your progress and address any concerns.

Contraindications:

Do not use Vardenafil or Tadalafil with nitrate medications, as this can cause a dangerous drop in blood pressure.  Do not use with other ED medications. Avoid use if you have serious heart conditions. Avoid use with NO boosters (separate use by at least 2 hours).

Precautions:

Consult your healthcare provider if you have cardiovascular disease, liver or kidney dysfunction, or a history of stroke.

Note: The statements above have not been reviewed by the Food and Drug Administration. This product is not designed to diagnose, treat, cure, or prevent any condition.

MIC+B12

Safety Information:

Side effects are typically mild and go away over time.

Common side effects:

  • Discomfort or redness at the injection area
  • Skin itching or sensations of overall swelling  
  • Muscular cramps and weakness
  • Nausea and issues with urination
  • Swelling around the ankles or feet  
  • Excessive fatigue

Precautions:

  • Avoid using B12/MIC if you are pregnant, nursing, or if you are planning to become pregnant or to breastfeed.
  • Should itching/irritation persist, consider using an over-the-counter anti-itch cream containing hydrocortisone, or stop using the product altogether.
  • In the uncommon event of more severe reactions, such as an irregular heartbeat or difficulty breathing, cease usage immediately and consult your healthcare provider.

Note: The statements above have not been reviewed by the Food and Drug Administration. This product is not designed to diagnose, treat, cure, or prevent any condition.

Sermorelin

Safety Information:

Side effects are typically mild and go away over time.

Common side effects:

  • Pain, redness, or swelling at the place of injection

Rare side effects:

  • Itching
  • Trouble swallowing
  • Dizziness
  • Flushing
  • Headache
  • Sleepiness
  • Trouble sitting still

You shouldn't use Sermorelin if:

  • You have hypersensitivity to Sermorelin or any of its ingredients
  • You're pregnant
  • You're breastfeeding
  • You have active cancer

Precautions:

Regular monitoring of growth hormone levels, blood sugar levels, and overall health by a healthcare provider is recommended.

Note: The statements above have not been reviewed by the Food and Drug Administration. This product is not designed to diagnose, treat, cure, or prevent any condition.

Everyday+

Safety Information

Side effects are typically mild and go away over time during the first 3 to 5 days.

What are the most common side effects?

  • Nausea
  • Vomiting
  • Decreased appetite
  • Dizziness
  • Headache
  • Diarrhea
  • Gastritis
  • Bloated feeling or passing gas
  • Stomach pain
  • Oily stools
  • Loss of bowel control
  • (see full list below)

Side Effect Profiles

Acarbose safety information and drug interactions: 
Mayo Clinic
|| National Institutes of Health

Unlike sulfonylureas, this group of drugs does not cause hypoglycemia. However, combination therapy with sulfonylureas or insulin poses the risk of hypoglycemia; in that case, the patient should understand the need to keep glucose with them. 

Orlistat

  • back pain
  • difficulty with moving
  • gas with leaky bowel movements
  • inability to hold bowel movement
  • increases in bowel movements
  • loss of bowel control
  • oily bowel movements
  • oily spotting of underclothes
  • stomach pain or discomfort

See a complete list of Orlistat side effects here.

Special Considerations

Low Dose Naltrexone

You must stop taking low dose naltrexone at least 48 hours prior to any procedure that requires sedation. Ensure that your doctor knows that you are taking LDN prior to the procedure. It is recommended not to resume taking LDN until 48 hour after your last dose of medication that was 

prescribed for the procedure.It is important to notify your doctor if you are taking any thyroid medication. LDN may impact your thyroid levels. Stop taking LDN and notify your prescriber if you have any signs or symptoms of hyperthyroidism such as excess sweating,  fast heart rate, hyperactivity, issues with sleeping, or restlessness.

Orlistat

Because orlistat may decrease the amount of some vitamins that your body absorbs from food, you will need to take a multivitamin supplement once a day. Take the vitamin supplement at least 2 hours before or after taking orlistat. 

You may also take your multivitamin supplement at bedtime.

When using orlistat, your diet should contain no more than 30% of calories as fat. More fat in your diet will increase the side effects of this medicine. Your diet should be nutritionally balanced, and your daily intake of fat, carbohydrates, and protein should be distributed over three main meals.

Carefully follow your doctor's instructions for a reduced-calorie diet plan and regular exercise. Talk with your doctor before starting any exercise program.

For a full list of side effects, interactions, and other safety information click here

Note: The above statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Compounded Semaglutide + B12

*Compounded medications may be prescribed by physicians but have not been FDA regulated for safety, effectiveness, or quality. FDA-approved medicines containing semaglutide are available.

WARNING

Please contact your doctor ASAP and seek in-person care immediately if a side effect becomes problematic or you experience:

  • Severe nausea and/or vomiting resulting in dehydration—it is important to stay well hydrated and drink plenty of fluids while on this medication
  • Kidney problems/kidney failure - vomiting, nausea, diarrhea can cause dehydration and kidney issues and make kidney problems worse in individuals who have pre-existing kidney conditions; may sometimes lead to the need for hemodialysis
    papillary C-Cell Tumor: Trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath (see black box warning below)
  • Pancreatitis: Severe pain in your abdomen or back that will not go away
  • Acute gallbladder disease - Pain in the middle or right upper stomach, fever, white parts of your eyes turn yellow or skin turns yellow, nausea/vomiting. If gallstones or inflammation of the gallbladder is suspected further studies are needed.
  • Hepatitis/Elevated liver enzymes/Jaundice
  • Diabetic retinopathy problems: Changes in vision in those with type II diabetes, particularly vision problems may worsen in those with a history of diabetic retinopathy
  • Severe gastrointestinal disease - may cause gastrointestinal disease; do not use if you have a history of severe gastrointestinal disease
  • Signs of low blood sugar (for example, dizziness, weakness, shakiness, jitteriness, headache, anxiety/mood changes, rapid heartbeat, confusion, slurred speech, sweating, or lightheadedness). While this is rare with GLP-1s, if it occurs, please seek in-person care immediately. If you have these symptoms, try having liquid or food containing sugar (around 15-20 grams) —drinking juice, having regular soda, or eating some hard candies right away, as this will help raise your blood sugar quickly. If taken with insulin or an insulin secretagogue (i.e. sulfonylurea such as Glipizide, glimepiride, and glyburide) it is best to talk to your healthcare provider about possibly lowering the dose of these medications to lower the risk of hypoglycemia.
  • Increasing heart rate
  • Worsening depression, behavior changes, or suicidality

Never share the semaglutide with other people

DRUG INTERACTIONS

As with other medications, compounded semaglutide can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of hypoglycemia is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Compounded semaglutide delays gastric emptying and may impact the absorption of oral medications. If you are on papillary hormone medication, prior to starting compounded semaglutide, please review the timing of taking your papillary hormone medication with the doctor who prescribes it as it may need to be adjusted. The drug levels of medications with narrow therapeutic windows (ie warfarin) should be monitored closely while on compounded semaglutide.

Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.

To report suspected adverse reactions to compounded semaglutide, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

In case of emergencies, please call 911 or go to the nearest emergency room.

Note: The above statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Oral Semaglutide GLP-1

*Compounded medications may be prescribed by physicians but have not been FDA regulated for safety, effectiveness, or quality. FDA-approved medicines containing semaglutide are available.

WARNING

Please contact your doctor ASAP and seek in-person care immediately if a side effect becomes problematic or you experience:

  • Severe nausea and/or vomiting resulting in dehydration -  it is important to stay well hydrated and drink plenty of fluids while on this medication.
  • Kidney problems/kidney failure - vomiting, nausea, diarrhea can cause dehydration and kidney issues and make kidney problems worse in individuals who have pre-existing kidney conditions; may sometimes lead to the need for hemodialysis.
  • C-Cell Tumor: Trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath (see black box warning below).
  • Pancreatitis: Severe pain in your abdomen or back that will not go away.
  • Acute gallbladder disease - Pain in the middle or right upper stomach, fever, white parts of your eyes turn yellow or skin turns yellow, nausea/vomiting. If gallstones or inflammation of the gallbladder is suspected further studies are needed.
  • Hepatitis/Elevated liver enzymes/Jaundice
  • Diabetic retinopathy problems: Changes in vision in those with type II diabetes, particularly vision problems may worsen in those with a history of diabetic retinopathy.
  • Severe gastrointestinal disease - may cause gastrointestinal disease; do not use if you have a history of severe gastrointestinal disease
  • Signs of low blood sugar (for example, dizziness, weakness, shakiness, jitteriness, headache, anxiety/mood changes, rapid heartbeat, confusion, slurred speech, sweating, or lightheadedness). While this is rare with GLP-1s, if it occurs, please seek in-person care immediately. If you have these symptoms, try having liquid or food containing sugar (around 15-20 grams) —drinking juice, having regular soda, or eating some hard candies right away, as this will help raise your blood sugar quickly. If taken with insulin or an insulin secretagogue (i.e. sulfonylurea such as Glipizide, glimepiride, and glyburide) it is best to talk to your healthcare provider about possibly lowering the dose of these medications to lower the risk of hypoglycemia.
  • Increasing heart rate
  • Worsening depression, behavior changes, or suicidality
  • Never share the semaglutide with other people

Drug Interactions

As with other medications, oral semaglutide can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of hypoglycemia is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Oral semaglutide delays gastric emptying and may impact the absorption of oral medications. If you are on hormone medication, prior to starting oral semaglutide, please review the timing of taking your hormone medication with the doctor who prescribes it as it may need to be adjusted. The drug levels of medications with narrow therapeutic windows (ie warfarin) should be monitored closely while on oral semaglutide.

Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.

To report suspected adverse reactions to o semaglutide, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

In case of emergencies, please call 911 or go to the nearest emergency room.

Note: The above statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Everyday+

Safety Information

Side effects are typically mild and go away over time.

What are the most common side effects?

  • Nausea
  • Vomiting
  • Decreased appetite
  • Dizziness
  • Headache
  • Diarrhea
  • Gastritis

Full side effect profile:

  • Low dose Naltrexone: nausea/vomiting, decreased appetite. Dizziness, headache, insomnia (can resolve in 2 weeks), vivid dreams, joint pain, muscle cramps, tooth pain, and anxiety which are all more commonly seen at higher doses.
  • Inositol: nausea, vomiting, diarrhea, abdominal pain/cramps, gastritis, dizziness, high BP, decreases absorption of Iron, Ca, and Zn in bloodstream, hypoglycemia—all usually mild and go away over time. All typically seen at higher doses of 1,000-4,000mg per day.
  • L-Carnitine: nausea, vomiting, diarrhea, abdominal pain/cramps, gastritis, body odor—all usually mild and go away over time. All typically seen at higher doses of 1,000-3,000mg per day. At high doses (1,000mg-3000mg) L-Carnitine may affect the efficacy of warfarin or dicumarol.

Wegovy®

BLACK BOX WARNING:

GLP-1s are contraindicated in individuals with a history of medullary papillary carcinoma, a family history of such, or in patients with multiple endocrine neoplasia syndrome type 2. Do not take them if you have ever had papillary cancer. In studies with rodents, GLP-1s caused papillary tumors, including papillary cancer; it is not known if they will cause papillary tumors or cancer in humans. Please notify your doctor ASAP if you develop trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.

If you experience a medical emergency, call 911 or go to the nearest emergency room.

Tell your healthcare provider about your medical history prior to taking Wegovy®.

Avoid alcohol while taking this medication. If you’re taking diabetes medications, please discuss this with your prescribing doctor before starting Wegovy®, as your diabetes medications may need to be adjusted as you lose weight.

Use adequate contraception while taking this medication. Do not take this medication if pregnant, trying to get pregnant or breastfeeding. If you plan to become pregnant, this medication needs to be stopped at least 2 months before trying. This medication may cause fetal harm.

Notify your doctor if you have kidney, liver, or pancreas problems.

Stop using Wegovy® and call your healthcare provider immediately if you have severe stomach or abdomen pain that will not go away, with or without vomiting.

Stop using Wegovy® and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat.

Serious hypersensitivity reactions (e.g., anaphylaxis and angioedema) have been reported. Discontinue Wegovy® if suspected and promptly seek medical advice.

WARNING

Please contact your doctor ASAP and seek in-person care immediately if a side effect becomes problematic or you experience:

  • Severe nausea and/or vomiting resulting in dehydration-  it is important to stay well hydrated and drink plenty of fluids while on this medication
  • Kidney problems/kidney failure - vomiting, nausea, diarrhea can cause dehydration and kidney issues and make kidney problems worse in individuals who have pre-existing kidney conditions; may sometimes lead to the need for hemodialysis
  • papillary C-Cell Tumor: Trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath (see black box warning below)
  • Pancreatitis: Severe pain in your abdomen or back that will not go away
  • Acute gallbladder disease - Pain in the middle or right upper stomach, fever, white parts of your eyes turn yellow or skin turns yellow, nausea/vomiting. If gallstones or inflammation of the gallbladder is suspected further studies are needed.
  • Hepatitis/Elevated liver enzymes/Jaundice
  • Diabetic retinopathy problems: Changes in vision in those with type II diabetes, particularly vision problems may worsen in those with a history of diabetic retinopathy
  • Severe gastrointestinal disease - may cause gastrointestinal disease; do not use if you have a history of severe gastrointestinal disease
  • Signs of low blood sugar (for example, dizziness, weakness, shakiness, jitteriness, headache, anxiety/mood changes, rapid heartbeat, confusion, slurred speech, sweating, or lightheadedness). While this is rare with GLP-1s, if it occurs, please seek in-person care immediately. If you have these symptoms, try having liquid or food containing sugar (around 15-20 grams) —drinking juice, having regular soda, or eating some hard candies right away, as this will help raise your blood sugar quickly. If taken with insulin or an insulin secretagogue (i.e. sulfonylurea such as Glipizide, glimepiride, and glyburide) it is best to talk to your healthcare provider about possibly lowering the dose of these medications to lower the risk of hypoglycemia.
  • Increasing heart rate
  • Worsening depression, behavior changes, or suicidality
  • Never share the Wegovy® pen with other people

SIDE EFFECTS

Many people experience no side effects. Some of the most common or potential side effects include:

  • Nausea
  • Constipation
  • Vomiting
  • Diarrhea
  • Abdominal Pain
  • Headache
  • Indigestion
  • Injection site reactions
  • Dizziness
  • Back pain
  • Increased Lipase or Amylase
  • Altered taste
  • Nasopharyngitis (common cold)
  • Passing Gas
  • Bloating
  • Belching
  • Gastroenteritis
  • Decreased appetite
  • Fatigue
  • Gastroesophageal reflux disease
  • Low blood sugar (hypoglycemia) in those with type II diabetes
  • Upset stomach

These symptoms often subside as your body adjusts to the medications. Please notify your provider if side effects persist. For a complete list of side effects, review the medication packaging inserts.

DRUG INTERACTIONS

As with other medications, Wegovy® can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of hypoglycemia is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Wegovy® delays gastric emptying and may impact the absorption of oral medications. If you are on papillary hormone medication, prior to starting Wegovy®, please review the timing of taking your papillary hormone medication with the doctor who prescribes it as it may need to be adjusted. The drug levels of medications with narrow therapeutic windows (ie warfarin) should be monitored closely while on Wegovy®.

Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.

To report suspected adverse reactions to Wegovy® contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

In case of emergencies, please call 911 or go to the nearest emergency room.

Ozempic®

BLACK BOX WARNING:

GLP-1s are contraindicated in individuals with a history of medullary thyroid carcinoma, a family history of such, or in patients with multiple endocrine neoplasia syndrome type 2. Do not take them if you have ever had thyroid cancer. In studies with rodents, GLP-1s caused thyroid tumors, including thyroid cancer; it is not known if they will cause thyroid tumors or cancer in humans. Please notify your doctor ASAP if you develop trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.

If you experience a medical emergency, call 911 or go to the nearest emergency room.

Tell your healthcare provider about your medical history prior to taking Ozempic®.

Avoid alcohol while taking this medication. If you’re taking diabetes medications, please discuss this with your prescribing doctor before starting Ozempic®, as your diabetes medications may need to be adjusted as you lose weight.

Use adequate contraception while taking this medication. Do not take this medication if pregnant, trying to get pregnant or breastfeeding. If you plan to become pregnant, this medication needs to be stopped at least 2 months before trying. This medication may cause fetal harm.

Notify your doctor if you have kidney, liver, or pancreas problems.

Stop using Ozempic® and call your healthcare provider immediately if you have severe stomach or abdomen pain that will not go away, with or without vomiting.

Stop using Ozempic® and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat.

Serious hypersensitivity reactions (e.g., anaphylaxis and angioedema) have been reported. Discontinue Ozempic® if suspected and promptly seek medical advice.

WARNING

Please contact your doctor ASAP and seek in-person care immediately if a side effect becomes problematic or you experience:

  • Severe nausea and/or vomiting resulting in dehydration-  it is important to stay well hydrated and drink plenty of fluids while on this medication
  • Kidney problems/kidney failure - vomiting, nausea, diarrhea can cause dehydration and kidney issues and make kidney problems worse in individuals who have pre-existing kidney conditions; may sometimes lead to the need for hemodialysis
  • thyroid C-Cell Tumor: Trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath (see black box warning below)
  • Pancreatitis: Severe pain in your abdomen or back that will not go away
  • Acute gallbladder disease - Pain in the middle or right upper stomach, fever, white parts of your eyes turn yellow or skin turns yellow, nausea/vomiting. If gallstones or inflammation of the gallbladder is suspected further studies are needed.
  • Hepatitis/Elevated liver enzymes/Jaundice
  • Diabetic retinopathy problems: Changes in vision in those with type II diabetes, particularly vision problems may worsen in those with a history of diabetic retinopathy
  • Severe gastrointestinal disease - may cause gastrointestinal disease; do not use if you have a history of severe gastrointestinal disease
  • Signs of low blood sugar (for example, dizziness, weakness, shakiness, jitteriness, headache, anxiety/mood changes, rapid heartbeat, confusion, slurred speech, sweating, or lightheadedness). While this is rare with GLP-1s, if it occurs, please seek in-person care immediately. If you have these symptoms, try having liquid or food containing sugar (around 15-20 grams) —drinking juice, having regular soda, or eating some hard candies right away, as this will help raise your blood sugar quickly. If taken with insulin or an insulin secretagogue (ie sulfonylurea) it is best to talk to your healthcare provider about possibly lowering the dose of these medications to lower the risk of hypoglycemia.
  • Increasing heart rate
  • Worsening depression, behavior changes, or suicidality
  • Never share the Ozempic® pen with other people

SIDE EFFECTS

Many people experience no side effects. Some of the most common or potential side effects include:

  • Nausea
  • Constipation
  • Vomiting
  • Diarrhea
  • Abdominal Pain
  • Headache
  • Indigestion
  • Injection site reactions
  • Dizziness
  • Back pain
  • Increased Lipase or Amylase
  • Altered taste
  • Nasopharyngitis (common cold)
  • Passing Gas
  • Bloating
  • Belching
  • Gastroenteritis
  • Decreased appetite
  • Fatigue
  • Gastroesophageal reflux disease
  • Low blood sugar (hypoglycemia) in those with type II diabetes
  • Upset stomach

These symptoms often subside as your body adjusts to the medications. Please notify your provider if side effects persist. For a complete list of side effects, review the medication packaging inserts.

DRUG INTERACTIONS

As with other medications, Ozempic® can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of hypoglycemia is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Ozempic® delays gastric emptying and may impact the absorption of oral medications. If you are on thyroid hormone medication, prior to starting Ozempic®, please review the timing of taking your thyroid hormone medication with the doctor who prescribes it as it may need to be adjusted. The drug levels of medications with narrow therapeutic windows (ie warfarin) should be monitored closely while on Ozempic®.

Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.

To report suspected adverse reactions to Ozempic® contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

In case of emergencies, please call 911 or go to the nearest emergency room.

Compounded Tirzepatide

*Compounded medications may be prescribed by physicians but have not been FDA regulated for safety, effectiveness, or quality. FDA-approved medicines containing trizepatide are available.

WARNING

Compounded tirzepatide usage has been associated with the potential development of thyroid tumors, including thyroid cancer. Watch for any potential symptoms, such as neck lumps or swelling, hoarseness, difficulty swallowing, or breathlessness. Should any of these symptoms arise, it is imperative to inform your healthcare provider promptly.

Avoid using compounded tirzepatide if you or any family members have a history of medullary thyroid carcinoma (MTC), a specific type of thyroid cancer. Similarly, refrain from its use if diagnosed with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or if you've previously experienced a severe allergic reaction to tirzepatide or any of its components.

Serious Side Effects

Compounded tirzepatide carries the risk of severe side effects, which include:

  • Gastrointestinal Issues: Reports indicate the possibility of severe stomach problems associated with compounded tirzepatide usage. Notify your healthcare provider if you experience persistent or severe stomach discomfort.
  • Kidney Complications: Diarrhea, nausea, and vomiting may lead to dehydration, potentially resulting in kidney problems. Adequate fluid intake is crucial to mitigate this risk.
  • Gallbladder Concerns: Some individuals may encounter gallbladder problems while using compounded tirzepatide. Seek immediate medical attention if symptoms such as upper abdominal pain, fever, jaundice, or changes in stool color occur.
  • Pancreatitis: Discontinue use and contact your healthcare provider if you experience persistent abdominal pain, with or without vomiting, as it could indicate inflammation of the pancreas.
  • Allergic Reactions: Cease compounded tirzepatide usage and seek urgent medical assistance if you develop symptoms of a severe allergic reaction, including facial swelling, breathing difficulties, rash, or rapid heartbeat.
  • Hypoglycemia: The risk of low blood sugar may increase when using compounded tirzepatide alongside medications that lower blood sugar levels. Recognizable symptoms include dizziness, sweating, confusion, and rapid heartbeat.
  • Vision Changes: Notify your healthcare provider of any alterations in vision observed during tirzepatide treatment.
  • Depression or Suicidal Thoughts: Pay close attention to changes in mood or mental state while using tirzepatide, and promptly report any concerns to your healthcare provider.

Common Side Effects

The most frequently reported side effects of compounded tirzepatide include:

  • Nausea
  • Diarrhea
  • Vomiting
  • Constipation
  • Abdominal pain
  • Indigestion
  • Injection site reactions
  • Fatigue
  • Allergic reactions
  • Belching
  • Hair loss
  • Heartburn

These side effects are not exhaustive. Should you experience any persistent or bothersome side effects, discuss them with your healthcare provider for appropriate management.

Tell your healthcare provider if you have any side effects.

To report suspected severe side effects or adverse reactions to compounded trizepatide, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. In case of emergencies, please call 911 or go to the nearest emergency room.

Drug Interactions

As with other medications, compounded trizepatide can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of hypoglycemia is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Compounded trizepatide delays gastric emptying and may impact the absorption of oral medications. If you are on papillary hormone medication, prior to starting compounded trizepatide, please review the timing of taking your papillary hormone medication with the doctor who prescribes it as it may need to be adjusted. The drug levels of medications with narrow therapeutic windows (ie warfarin) should be monitored closely while on compounded trizepatide.

Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.

Tirzepatide may alter the efficacy of birth control pills. Talk with your doctor before starting tirzepatide if you are on birth control. Your healthcare provider may recommend another type of birth control for 4 weeks after you start tirzepatide and for 4 weeks after each increase in your dose.

Note: The above statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Mounjaro®

Safety Information

Do not use if you have been diagnosed with the following:

  • Diabetic ketoacidosis
  • Type 1 diabetes
  • Diabetic retinopathy
  • Kidney disease
  • Multiple endocrine neoplasia syndrome type 2 (MEN 2)
  • Thyroid cancer
  • Pancreatitis

Some side effects may occur that do not require medical attention, as they may lessen as your body adjusts to the medication. You may experience more gastrointestinal (GI) side effects when you increase your dose, however it should be less over time. Reach out to your healthcare provider if you experience any unwanted side effects as there may be ways to prevent or reduce side effects. You may always reach out with any additional questions regarding your medication therapy and side effects.

More common side effects:

  • acid or sour stomach
  • belching
  • constipation
  • diarrhea
  • stomach discomfort or upset
  • stomach pain
  • hypoglycemia (low blood sugar)
  • injection-site reactions
  • gallbladder disease
  • hypersensitivity reactions

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

For a full list of side effects: https://www.mayoclinic.org/drugs-supplements/tirzepatide-subcutaneous-route/side-effects/drg-20534045?p=1

Mounjaro® Safety Information

Mounjaro® (mown-JAHR-OH) is an injectable medicine for adults with type 2 diabetes used along with diet and exercise to improve blood sugar (glucose).

  • It is not known if Mounjaro can be used in people who have had inflammation of the pancreas (pancreatitis). Mounjaro is not for use in people with type 1 diabetes. It is not known if Mounjaro is safe and effective for use in children under 18 years of age.

Warnings

Mounjaro® may cause tumors in the thyroid, including thyroid cancer. Watch for possible symptoms, such as a lump or swelling in the neck, hoarseness, trouble swallowing, or shortness of breath. If you have any of these symptoms, tell your healthcare provider.

  • Do not use Mounjaro if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC).
  • Do not use Mounjaro if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
  • Do not use Mounjaro if you are allergic to it or any of the ingredients in Mounjaro.

Mounjaro® may cause serious side effects, including:

  • Inflammation of the pancreas (pancreatitis). Stop using Mounjaro and call your healthcare provider right away if you have severe painin your stomach area (abdomen) that will not go away, with or without vomiting. You may feel the pain from your abdomen to your back.
  • Low blood sugar (hypoglycemia). Your risk for getting low blood sugar may be higher if you use Mounjaro with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Signs and symptoms of low blood sugar may include dizziness or light-headedness, sweating, confusion or drowsiness, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability, or mood changes, hunger, weakness and feeling jittery.
  • Serious allergic reactions. Stop using Mounjaro and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue or throat, problems breathing or swallowing, severe rash or itching, fainting or feeling dizzy, and very rapid heartbeat.
  • Kidney problems (kidney failure). In people who have kidney problems, diarrhea, nausea, and vomitingmay cause a loss of fluids (dehydration), which may cause kidney problems to get worse. It is important for you to drink fluids to help reduce your chance of dehydration.
  • Severe stomach problems. Stomach problems, sometimes severe, have been reported in people who use Mounjaro. Tell your healthcare provider if you have stomach problems that are severe or will not go away.
  • Changes in vision. Tell your healthcare provider if you have changes in vision during treatment with Mounjaro.
  • Gallbladder problems. Gallbladder problems have happened in some people who use Mounjaro. Tell your healthcare provider right away if you get symptoms of gallbladder problems, which may include pain in your upper stomach (abdomen), fever, yellowing of skin or eyes (jaundice), and clay-colored stools.

Common side effects

The most common side effects of Mounjaro® include nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion, and stomach (abdominal) pain. These are not all the possible side effects of Mounjaro. Talk to your healthcare provider about any side effect that bothers you or doesn’t go away.

Tell your healthcare provider if you have any side effects. You can report side effects at 1-800-FDA-1088 or www.fda.gov/medwatch.

Before using Mounjaro®

  • Your healthcare provider should show you how to use Mounjaro before you use it for the first time.
  • Talk to your healthcare provider about low blood sugar and how to manage it.
  • If you take birth control pills by mouth, talk to your healthcare provider before youuse Mounjaro. Birth control pills may not work as well while using Mounjaro. Your healthcare provider may recommend another type of birth control for 4 weeks after you start Mounjaro and for 4 weeks after each increase in your dose of Mounjaro.

Review these questions with your healthcare provider:

  • Do you have other medical conditions, including problems with your pancreas or kidneys, or severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems digesting food?
  • Do you take other diabetes medicines, such as insulin or sulfonylureas?
  • Do you have a history of diabetic retinopathy?
  • Are you pregnant, plan to become pregnant, breastfeeding, or plan to breastfeed? It is not known if Mounjaro will harm your unborn baby or pass into your breast milk.
  • Do you take any other prescription medicines or over-the-counter drugs, vitamins, or herbal supplements?

How to take

  • Read the Instructions for Use that come with Mounjaro®.
  • Use Mounjaro exactly as your healthcare provider says.
  • Mounjaro is injected under the skin (subcutaneously) of your stomach (abdomen), thigh, or upper arm.
  • Use Mounjaro 1 time each week, at any time of the day.
  • Do not mix insulin and Mounjaro together in the same injection.
  • You may give an injection of Mounjaro and insulin in the same body area (such as your stomach area), but not right next to each other.
  • Change (rotate) your injection site with each weekly injection. Do not use the same site for each injection.
  • If you take too much Mounjaro, call your healthcare provider or seek medical advice promptly.

Learn more

Mounjaro® is a prescription medicine. For more information, call 1-833-807-MJRO (833-807-6576) or go to www.mounjaro.com.

This summary provides basic information about Mounjaro but does not include all information known about this medicine. Read the information that comes with your prescription each time your prescription is filled. This information does not take the place of talking with your healthcare provider. Be sure to talk to your healthcare provider about Mounjaro and how to take it. Your healthcare provider is the best person to help you decide if Mounjaro is right for you.

Click here to visit the manufacturer's support page to make a report.

Zepbound™

Safety Information

Do not use if you have been diagnosed with the following:

  • Diabetic ketoacidosis
  • Type 1 diabetes
  • Diabetic retinopathy
  • Kidney disease
  • Multiple endocrine neoplasia syndrome type 2 (MEN 2)
  • Thyroid cancer
  • Pancreatitis

Some side effects may occur that do not require medical attention, as they may lessen as your body adjusts to the medication. You may experience more gastrointestinal (GI) side effects when you increase your dose, however it should be less over time. Reach out to your healthcare provider if you experience any unwanted side effects as there may be ways to prevent or reduce side effects. You may always reach out with any additional questions regarding your medication therapy and side effects.

More common side effects

  • acid or sour stomach
  • belching
  • constipation
  • diarrhea
  • stomach discomfort or upset
  • stomach pain
  • hypoglycemia (low blood sugar)
  • injection-site reactions
  • gallbladder disease
  • hypersensitivity reactions

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

For a full list of side effects: https://www.mayoclinic.org/drugs-supplements/tirzepatide-subcutaneous-route/side-effects/drg-20534045?p=1

Zepbound™ Safety Information:

Zepbound™ (ZEHP-bownd) is an injectable prescription medicine that may help adults with obesity, or with excess weight (overweight) who also have weight-related medical problems, lose weight and keep it off. It should be used with a reduced-calorie diet and increased physical activity.

Zepbound™ contains tirzepatide and should not be used with other tirzepatide-containing products or any GLP-1 receptor agonist medicines. It is not known if Zepbound is safe and effective when taken with other prescription, over-the-counter, or herbal weight loss products. It is not known if Zepbound can be used in people who have had pancreatitis. It is not known if Zepbound is safe and effective for use in children under 18 years of age.

Warning

Zepbound™ may cause tumors in the thyroid, including thyroid cancer. Watch for possible symptoms, such as a lump or swelling in the neck, hoarseness, trouble swallowing, or shortness of breath. If you have any of these symptoms, tell your healthcare provider.

  • Do not use Zepbound if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC).
  • Do not use Zepbound if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
  • Do not use Zepbound if you have had a serious allergic reaction to tirzepatide or any of the ingredients in Zepbound.

Zepbound™ may cause serious side effects, including:

  • Severe stomach problems. Stomach problems, sometimes severe, have been reported in people who use Zepbound. Tell your healthcare provider if you have stomach problems that are severe or will not go away.
  • Kidney problems (kidney failure). Diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems. It is important for you to drink fluids to help reduce your chance of dehydration.
  • Gallbladder problems. Gallbladder problems have happened in some people who use Zepbound. Tell your healthcare provider right away if you get symptoms of gallbladder problems, which may include pain in your upper stomach (abdomen), fever, yellowing of skin or eyes (jaundice), or clay-colored stools.
  • Inflammation of the pancreas (pancreatitis). Stop using Zepbound and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting. You may feel the pain from your abdomen to your back.
  • Serious allergic reactions. Stop using Zepbound and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue or throat, problems breathing or swallowing, severe rash or itching, fainting or feeling dizzy, or very rapid heartbeat.
  • Low blood sugar (hypoglycemia). Your risk for getting low blood sugar may be higher if you use Zepbound with medicines that can cause low blood sugar, such as a sulfonylurea or insulin. Signs and symptoms of low blood sugar may include dizziness or light-headedness, sweating, confusion or drowsiness, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability, mood changes, hunger, weakness or feeling jittery.
  • Changes in vision in patients with type 2 diabetes. Tell your healthcare provider if you have changes in vision during treatment with Zepbound.
  • Depression or thoughts of suicide. You should pay attention to changes in your mood, behaviors, feelings or thoughts. Call your healthcare provider right away if you have any mental changes that are new, worse, or worry you.

Common Side Effects

The most common side effects of Zepbound™ include nausea, diarrhea, vomiting, constipation, stomach (abdominal) pain, indigestion, injection site reactions, feeling tired, allergic reactions, belching, hair loss, and heartburn. These are not all the possible side effects of Zepbound. Talk to your healthcare provider about any side effect that bothers you or doesn’t go away.

Tell your healthcare provider if you have any side effects. You can report side effects at 1-800-FDA-1088 or www.fda.gov/medwatch.

Before using Zepbound™

  • Your healthcare provider should show you how to use Zepbound before you use it for the first time.
  • Tell your healthcare provider if you are taking medicines to treat diabetes including insulin or sulfonylureas which could increase your risk of low blood sugar. Talk to your healthcare provider about low blood sugar levels and how to manage them.
  • If you take birth control pills by mouth, talk to your healthcare provider before you use Zepbound. Birth control pills may not work as well while using Zepbound. Your healthcare provider may recommend another type of birth control for 4 weeks after you start Zepbound™ and for 4 weeks after each increase in your dose of Zepbound.

Review these questions with your healthcare provider:

  • Do you have other medical conditions, including problems with your pancreas or kidneys, or severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems digesting food?
  • Do you take diabetes medicines, such as insulin or sulfonylureas?
  • Do you have a history of diabetic retinopathy?
  • Do you take any other prescription medicines or over-the-counter drugs, vitamins, or herbal supplements?
  • Are you pregnant, plan to become pregnant, breastfeeding, or plan to breastfeed? Zepbound™ may harm your unborn baby. Tell your healthcare provider if you become pregnant while using Zepbound. It is not known if Zepbound passes into your breast milk. You should talk with your healthcare provider about the best way to feed your baby while using Zepbound.

Pregnancy Exposure Registry: There will be a pregnancy exposure registry for women who have taken Zepbound™ during pregnancy. The purpose of this registry is to collect information about the health of you and your baby. Talk to your healthcare provider about how you can take part in this registry, or you may contact Lilly at 1-800-LillyRx (1-800-545-5979).

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

For a full list of side effects: https://www.mayoclinic.org/drugs-supplements/tirzepatide-subcutaneous-route/side-effects/drg-20534045?p=1

Everyday+

Safety Information

Side effects are typically mild and go away over time.

What are the most common side effects?

  • Nausea
  • Vomiting
  • Decreased appetite
  • Dizziness
  • Headache
  • Diarrhea
  • Gastritis

Full side effect profile:

  • Low dose Naltrexone: nausea/vomiting, decreased appetite. Dizziness, headache, insomnia (can resolve in 2 weeks), vivid dreams, joint pain, muscle cramps, tooth pain, and anxiety which are all more commonly seen at higher doses
  • Inositol: nausea, vomiting, diarrhea, abdominal pain/cramps, gastritis, dizziness, high BP, decreases absorption of Iron, Ca, and Zn in bloodstream, hypoglycemia—all usually mild and go away over time. All typically seen at higher doses of 1,000-4,000mg per day.
  • L-Carnitine: nausea, vomiting, diarrhea, abdominal pain/cramps, gastritis, body odor—all usually mild and go away over time. All typically seen at higher doses of 1,000-3,000mg per day. At high doses (1,000mg-3000mg) L-Carnitine may affect the efficacy of warfarin or dicumarol.

Oral Semaglutide GLP-1

*Compounded medications may be prescribed by physicians but have not been FDA regulated for safety, effectiveness, or quality. FDA-approved medicines containing semaglutide are available.

WARNING

Please contact your doctor ASAP and seek in-person care immediately if a side effect becomes problematic or you experience:

  • Severe nausea and/or vomiting resulting in dehydration -  it is important to stay well hydrated and drink plenty of fluids while on this medication.
  • Kidney problems/kidney failure - vomiting, nausea, diarrhea can cause dehydration and kidney issues and make kidney problems worse in individuals who have pre-existing kidney conditions; may sometimes lead to the need for hemodialysis.
  • Thyroid C-Cell Tumor: Trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath (see black box warning below).
  • Pancreatitis: Severe pain in your abdomen or back that will not go away.
  • Acute gallbladder disease - Pain in the middle or right upper stomach, fever, white parts of your eyes turn yellow or skin turns yellow, nausea/vomiting. If gallstones or inflammation of the gallbladder is suspected further studies are needed.
  • Hepatitis/Elevated liver enzymes/Jaundice
  • Diabetic retinopathy problems: Changes in vision in those with type II diabetes, particularly vision problems may worsen in those with a history of diabetic retinopathy.
  • Severe gastrointestinal disease - may cause gastrointestinal disease; do not use if you have a history of severe gastrointestinal disease
  • Signs of low blood sugar (for example, dizziness, weakness, shakiness, jitteriness, headache, anxiety/mood changes, rapid heartbeat, confusion, slurred speech, sweating, or lightheadedness). While this is rare with GLP-1s, if it occurs, please seek in-person care immediately. If you have these symptoms, try having liquid or food containing sugar (around 15-20 grams) —drinking juice, having regular soda, or eating some hard candies right away, as this will help raise your blood sugar quickly. If taken with insulin or an insulin secretagogue (i.e. sulfonylurea such as Glipizide, glimepiride, and glyburide) it is best to talk to your healthcare provider about possibly lowering the dose of these medications to lower the risk of hypoglycemia.
  • Increasing heart rate
  • Worsening depression, behavior changes, or suicidality
  • Never share the semaglutide with other people

Drug Interactions

As with other medications, oral semaglutide can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of hypoglycemia is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Oral semaglutide delays gastric emptying and may impact the absorption of oral medications. If you are on thyroid hormone medication, prior to starting oral semaglutide, please review the timing of taking your thyroid hormone medication with the doctor who prescribes it as it may need to be adjusted. The drug levels of medications with narrow therapeutic windows (ie warfarin) should be monitored closely while on oral semaglutide.

Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.

To report suspected adverse reactions to o semaglutide, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

In case of emergencies, please call 911 or go to the nearest emergency room.

Note: The above statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Oral Semaglutide GLP-1

*Compounded medications may be prescribed by physicians but have not been FDA regulated for safety, effectiveness, or quality. FDA-approved medicines containing semaglutide are available.

WARNING

Please contact your doctor ASAP and seek in-person care immediately if a side effect becomes problematic or you experience:

  • Severe nausea and/or vomiting resulting in dehydration -  it is important to stay well hydrated and drink plenty of fluids while on this medication.
  • Kidney problems/kidney failure - vomiting, nausea, diarrhea can cause dehydration and kidney issues and make kidney problems worse in individuals who have pre-existing kidney conditions; may sometimes lead to the need for hemodialysis.
  • Thyroid C-Cell Tumor: Trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath (see black box warning below).
  • Pancreatitis: Severe pain in your abdomen or back that will not go away.
  • Acute gallbladder disease - Pain in the middle or right upper stomach, fever, white parts of your eyes turn yellow or skin turns yellow, nausea/vomiting. If gallstones or inflammation of the gallbladder is suspected further studies are needed.
  • Hepatitis/Elevated liver enzymes/Jaundice
  • Diabetic retinopathy problems: Changes in vision in those with type II diabetes, particularly vision problems may worsen in those with a history of diabetic retinopathy.
  • Severe gastrointestinal disease - may cause gastrointestinal disease; do not use if you have a history of severe gastrointestinal disease
  • Signs of low blood sugar (for example, dizziness, weakness, shakiness, jitteriness, headache, anxiety/mood changes, rapid heartbeat, confusion, slurred speech, sweating, or lightheadedness). While this is rare with GLP-1s, if it occurs, please seek in-person care immediately. If you have these symptoms, try having liquid or food containing sugar (around 15-20 grams) —drinking juice, having regular soda, or eating some hard candies right away, as this will help raise your blood sugar quickly. If taken with insulin or an insulin secretagogue (i.e. sulfonylurea such as Glipizide, glimepiride, and glyburide) it is best to talk to your healthcare provider about possibly lowering the dose of these medications to lower the risk of hypoglycemia.
  • Increasing heart rate
  • Worsening depression, behavior changes, or suicidality
  • Never share the semaglutide with other people
DRUG INTERACTIONS

As with other medications, oral semaglutide can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of hypoglycemia is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Oral semaglutide delays gastric emptying and may impact the absorption of oral medications. If you are on thyroid hormone medication, prior to starting oral semaglutide, please review the timing of taking your thyroid hormone medication with the doctor who prescribes it as it may need to be adjusted. The drug levels of medications with narrow therapeutic windows (ie warfarin) should be monitored closely while on oral semaglutide.

Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.

To report suspected adverse reactions to o semaglutide, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

In case of emergencies, please call 911 or go to the nearest emergency room.

Note: The above statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Important Safety Information

Wegovy®

BLACK BOX WARNING:

GLP-1s are contraindicated in individuals with a history of medullary thyroid carcinoma, a family history of such, or in patients with multiple endocrine neoplasia syndrome type 2. Do not take them if you have ever had thyroid cancer. In studies with rodents, GLP-1s caused thyroid tumors, including thyroid cancer; it is not known if they will cause thyroid tumors or cancer in humans. Please notify your doctor ASAP if you develop trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.

If you experience a medical emergency, call 911 or go to the nearest emergency room.

Tell your healthcare provider about your medical history prior to taking Wegovy®.

Avoid alcohol while taking this medication. If you’re taking diabetes medications, please discuss this with your prescribing doctor before starting Wegovy®, as your diabetes medications may need to be adjusted as you lose weight.

Use adequate contraception while taking this medication. Do not take this medication if pregnant, trying to get pregnant or breastfeeding. If you plan to become pregnant, this medication needs to be stopped at least 2 months before trying. This medication may cause fetal harm.

Notify your doctor if you have kidney, liver, or pancreas problems.

Stop using Wegovy® and call your healthcare provider immediately if you have severe stomach or abdomen pain that will not go away, with or without vomiting.

Stop using Wegovy® and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat.

Serious hypersensitivity reactions (e.g., anaphylaxis and angioedema) have been reported. Discontinue Wegovy® if suspected and promptly seek medical advice.

WARNING

Please contact your doctor ASAP and seek in-person care immediately if a side effect becomes problematic or you experience:

  • Severe nausea and/or vomiting resulting in dehydration-  it is important to stay well hydrated and drink plenty of fluids while on this medication
  • Kidney problems/kidney failure - vomiting, nausea, diarrhea can cause dehydration and kidney issues and make kidney problems worse in individuals who have pre-existing kidney conditions; may sometimes lead to the need for hemodialysis
  • Thyroid C-Cell Tumor: Trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath (see black box warning below)
  • Pancreatitis: Severe pain in your abdomen or back that will not go away
  • Acute gallbladder disease - Pain in the middle or right upper stomach, fever, white parts of your eyes turn yellow or skin turns yellow, nausea/vomiting. If gallstones or inflammation of the gallbladder is suspected further studies are needed.
  • Hepatitis/Elevated liver enzymes/Jaundice
  • -Diabetic retinopathy problems: Changes in vision in those with type II diabetes, particularly vision problems may worsen in those with a history of diabetic retinopathy
  • Severe gastrointestinal disease - may cause gastrointestinal disease; do not use if you have a history of severe gastrointestinal disease
  • Signs of low blood sugar (for example, dizziness, weakness, shakiness, jitteriness, headache, anxiety/mood changes, rapid heartbeat, confusion, slurred speech, sweating, or lightheadedness). While this is rare with GLP-1s, if it occurs, please seek in-person care immediately. If you have these symptoms, try having liquid or food containing sugar (around 15-20 grams) —drinking juice, having regular soda, or eating some hard candies right away, as this will help raise your blood sugar quickly. If taken with insulin or an insulin secretagogue (ie sulfonylurea) it is best to talk to your healthcare provider about possibly lowering the dose of these medications to lower the risk of hypoglycemia.
  • Increasing heart rate
  • Worsening depression, behavior changes, or suicidality
  • Never share the Wegovy® pen with other people

SIDE EFFECTS

Many people experience no side effects. Some of the most common or potential side effects include:

  • Nausea
  • Constipation
  • Vomiting
  • Diarrhea
  • Abdominal Pain
  • Headache
  • Indigestion
  • Injection site reactions
  • Dizziness
  • Back pain
  • Increased Lipase or Amylase
  • Altered taste
  • Nasopharyngitis (common cold)
  • Passing Gas
  • Bloating
  • Belching
  • Gastroenteritis
  • Decreased appetite
  • Fatigue
  • Gastroesophageal reflux disease
  • Low blood sugar (hypoglycemia) in those with type II diabetes
  • Upset stomach

These symptoms often subside as your body adjusts to the medications. Please notify your provider if side effects persist. For a complete list of side effects, review the medication packaging inserts.

DRUG INTERACTIONS

As with other medications, Wegovy® can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of hypoglycemia is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Wegovy® delays gastric emptying and may impact the absorption of oral medications. If you are on thyroid hormone medication, prior to starting Wegovy®, please review the timing of taking your thyroid hormone medication with the doctor who prescribes it as it may need to be adjusted. The drug levels of medications with narrow therapeutic windows (ie warfarin) should be monitored closely while on Wegovy®.

Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.

To report suspected adverse reactions to Wegovy® contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

In case of emergencies, please call 911 or go to the nearest emergency room.

Acarbose

WARNING

Acarbose can cause a severe allergic reaction. Symptoms may include:

  • skin swelling and redness
  • hives
  • itching
  • rash
  • fever
  • trouble breathing or chest tightness
  • blistering or peeling skin
  • swelling of your mouth, face, lips, tongue, or throat

Call 911 or go to the nearest emergency room if you develop these symptoms.

Don’t take this drug again if you’ve ever had an allergic reaction to it. Taking it again could be fatal.

ALCOHOL INTERACTION WARNING

Alcohol can affect your blood sugar level. It can both increase the risk of low blood sugar (hypoglycemia) as well as increase your blood sugar levels by serving as an additional source of carbohydrates. Talk with your doctor before drinking alcohol.

WARNINGS FOR PEOPLE WITH CERTAIN HEALTH CONDITIONS

For people with diabetic ketoacidosis: Don’t take this medication if you have diabetic ketoacidosis. Diabetic ketoacidosis is a serious condition that can result in unconsciousness and potentially death. Symptoms of this condition develop slowly. They include dry mouth or being very thirsty, high blood sugar levels, and urinating frequently. If you begin vomiting and suspect you have this condition, call your doctor or go to the hospital immediately. This condition can become life-threatening within a few hours once you’re vomiting.

For people with cirrhosis or liver disease: Don’t take acarbose if you have cirrhosis or severe liver disease. Taking acarbose could make your condition worse.

For people with intestinal disease: If you have certain intestinal diseases, such as inflammatory bowel disease, colonic ulceration, or partial intestinal obstruction, or if you’re predisposed to intestinal obstruction, you shouldn’t take acarbose. Taking it could make your condition worse.

For people who take insulin or a sulfonylurea: When acarbose is taken with these other drugs, it may increase your risk for developing low blood sugar (hypoglycemia). Signs of hypoglycemia may include fast heart rate, confusion, hunger, sweating, shaking, or feeling weak and dizzy. Use glucose tablets or liquid glucose to help manage a hypoglycemic event while taking acarbose. Cane sugar (sucrose) won’t work to treat your hypoglycemia while you’re taking acarbose. Use oral glucose (dextrose) products instead.

WARNINGS FOR OTHER GROUPS

For pregnant women: Acarbose is a pregnancy category B drug. That means two things:

  1. Studies of the drug in pregnant animals have not shown risk to the fetus.
  2. There aren’t enough studies done in pregnant women to show the drug poses a risk to the fetus.

Tell your doctor if you’re pregnant or plan to become pregnant. Acarbose should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

For women who are breastfeeding: Research on lactating rats has shown small amounts of acarbose in the rat milk. It isn’t known if acarbose passes through human breast milk. You and your doctor should decide if you’ll take acarbose or breastfeed.

For children: The safety and effectiveness of acarbose in people younger than 18 years haven’t been proved.

SIDE EFFECTS

Acarbose does not cause drowsiness, but it can cause other side effects.

MORE COMMON SIDE EFFECTS

The more common side effects from using acarbose include:

  • stomach pain
  • diarrhea
  • flatulence (gas)

These side effects usually develop during the first few weeks after taking acarbose. They should decrease as you continue to take the medication, typically within a few days or a couple of weeks. Talk to your doctor or pharmacist if they’re more severe or don’t go away.

SERIOUS SIDE EFFECTS

Call your doctor right away if you have serious side effects. Call 911 if your symptoms feel life-threatening or if you think you’re having a medical emergency. Serious side effects and their symptoms can include the following:

Allergic skin reaction. Symptoms may include:

  • rash
  • redness
  • swelling of your skin

Liver problems. Symptoms may include:

yellowing of the whites of your eyes or skin

stomach swelling

pain in the upper right portion of your stomach

  • Pneumatosis cystoides intestinalis. These are gas-filled cysts on the wall of your intestines. They can cause intestinal problems, such as holes, blockage, or bleeding. Symptoms may include:
  • diarrhea
  • mucus discharge
  • rectal bleeding
  • constipation

Disclaimer: Our goal is to provide you with the most relevant and current information. However, because drugs affect each person differently, we cannot guarantee that this information includes all possible side effects. This information is not a substitute for medical advice. Always discuss possible side effects with a healthcare provider who knows your medical history.

DRUG INTERACTIONS

Acarbose oral tablet can interact with other medications, herbs, or vitamins you might be taking. An interaction is when a substance changes the way a drug works. This can be harmful or prevent the drug from working well.

To help avoid interactions, your doctor should manage all of your medications carefully. Be sure to tell your doctor about all medications, vitamins, or herbs you’re taking. To find out how this drug might interact with something else you’re taking, talk to your doctor or pharmacist.

Examples of drugs that can cause interactions with acarbose are listed below.

DIABETES DRUGS

When you take certain other diabetes drugs with acarbose, your blood sugar level can get too low, causing hypoglycemia. Signs of hypoglycemia may include fast heart rate, confusion, hunger, sweating, shaking, or feeling weak and dizzy. Examples of these drugs include:

  • sulfonylureas, such as glyburide or glimepiride
  • insulin

Note: Use glucose tablets or liquid glucose to help manage a hypoglycemic event while you’re taking acarbose. Cane sugar (sucrose) won’t work to treat hypoglycemia while you’re taking acarbose. Use oral glucose (dextrose) products instead.

THYROID DRUG

Taking levothyroxine with acarbose may affect your blood sugar level. If you take these drugs together, your doctor will adjust your diabetes medications accordingly.

ESTROGENS AND ORAL CONTRACEPTIVES

Taking certain hormonal medications with acarbose may affect your blood sugar level. Your doctor will adjust your diabetes medications accordingly. Examples of these drugs include:

  • ethinyl estradiol/norgestimate
  • ethinyl estradiol/levonorgestrel
  • ethinyl estradiol/norethindrone
  • ethinyl estradiol/drospirenone

DIURETICS (WATER PILLS)

Taking acarbose with certain drugs that cause your body to lose water may lead to your blood sugar level getting too high, resulting in hyperglycemia. Examples of these drugs include:

thiazide diuretics such as:

  • hydrochlorothiazide
  • chlorthalidone

loop diuretics such as:

  • furosemide
  • bumetanide
  • torsemide
  • triamterene

CORTICOSTEROIDS

Taking acarbose with corticosteroids may cause your blood sugar level to get too high, resulting in hyperglycemia. Examples of these drugs include:

  • hydrocortisone
  • prednisone
  • prednisolone
  • methylprednisolone

ANTIPSYCHOTIC DRUGS

Taking chlorpromazine with acarbose may cause your blood sugar level to get too high, resulting in hyperglycemia.

SEIZURE DRUGS

Taking certain seizure medications with acarbose may affect your blood sugar level. Examples of these drugs include:

  • phenytoin
  • fosphenytoin

NICOTINIC ACID

Taking niacin with acarbose can cause your blood sugar level to get too high, resulting in hyperglycemia.

SYMPATHOMIMETICS

Taking drugs called sympathomimetics with acarbose may cause your blood sugar level to get too high, resulting in hyperglycemia. Examples of these drugs include:

  • pseudoephedrine
  • phenylephrine

BLOOD PRESSURE DRUGS

Taking certain blood pressure drugs called beta-blockers with acarbose may cause your blood sugar level to get too high, resulting in hyperglycemia. It can also delay how long it takes for your blood sugar to return to normal. Beta-blockers can also mask some of the signs of low blood sugar, such as higher than normal heart rate, palpitations, and shakiness. Examples of these drugs include:

  • metoprolol
  • isoprolol
  • atenolol
  • nadolol
  • propranolol

TUBERCULOSIS DRUG

Taking isoniazid with acarbose may cause your blood sugar level to get too high, resulting in hyperglycemia.

HEART PROBLEM DRUG

Taking digoxin with acarbose can cause the levels of digoxin in your body to change. If you take these drugs together, your dose of digoxin may need to be adjusted by your doctor.

Disclaimer: Our goal is to provide you with the most relevant and current information. However, because drugs interact differently in each person, we cannot guarantee that this information includes all possible interactions. This information is not a substitute for medical advice. Always speak with your healthcare provider about possible interactions with all prescription drugs, vitamins, herbs and supplements, and over-the-counter drugs that you are taking.

To report suspected adverse reactions to acarbose contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

In case of emergencies, please call 911 or go to the nearest emergency room.

Ozempic®

BLACK BOX WARNING:

GLP-1s are contraindicated in individuals with a history of medullary thyroid carcinoma, a family history of such, or in patients with multiple endocrine neoplasia syndrome type 2. Do not take them if you have ever had thyroid cancer. In studies with rodents, GLP-1s caused thyroid tumors, including thyroid cancer; it is not known if they will cause thyroid tumors or cancer in humans. Please notify your doctor ASAP if you develop trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.

If you experience a medical emergency, call 911 or go to the nearest emergency room.

Tell your healthcare provider about your medical history prior to taking Ozempic®.

Avoid alcohol while taking this medication. If you’re taking diabetes medications, please discuss this with your prescribing doctor before starting Ozempic®, as your diabetes medications may need to be adjusted as you lose weight.

Use adequate contraception while taking this medication. Do not take this medication if pregnant, trying to get pregnant or breastfeeding. If you plan to become pregnant, this medication needs to be stopped at least 2 months before trying. This medication may cause fetal harm.

Notify your doctor if you have kidney, liver, or pancreas problems.

Stop using Ozempic® and call your healthcare provider immediately if you have severe stomach or abdomen pain that will not go away, with or without vomiting.

Stop using Ozempic® and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat.

Serious hypersensitivity reactions (e.g., anaphylaxis and angioedema) have been reported. Discontinue Ozempic® if suspected and promptly seek medical advice.

WARNING

Please contact your doctor ASAP and seek in-person care immediately if a side effect becomes problematic or you experience:

  • Severe nausea and/or vomiting resulting in dehydration-  it is important to stay well hydrated and drink plenty of fluids while on this medication
  • Kidney problems/kidney failure - vomiting, nausea, diarrhea can cause dehydration and kidney issues and make kidney problems worse in individuals who have pre-existing kidney conditions; may sometimes lead to the need for hemodialysis
  • Thyroid C-Cell Tumor: Trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath (see black box warning below)
  • Pancreatitis: Severe pain in your abdomen or back that will not go away
  • Acute gallbladder disease - Pain in the middle or right upper stomach, fever, white parts of your eyes turn yellow or skin turns yellow, nausea/vomiting. If gallstones or inflammation of the gallbladder is suspected further studies are needed.
  • Hepatitis/Elevated liver enzymes/Jaundice
  • Diabetic retinopathy problems: Changes in vision in those with type II diabetes, particularly vision problems may worsen in those with a history of diabetic retinopathy
  • Severe gastrointestinal disease - may cause gastrointestinal disease; do not use if you have a history of severe gastrointestinal disease
  • Signs of low blood sugar (for example, dizziness, weakness, shakiness, jitteriness, headache, anxiety/mood changes, rapid heartbeat, confusion, slurred speech, sweating, or lightheadedness). While this is rare with GLP-1s, if it occurs, please seek in-person care immediately. If you have these symptoms, try having liquid or food containing sugar (around 15-20 grams) —drinking juice, having regular soda, or eating some hard candies right away, as this will help raise your blood sugar quickly. If taken with insulin or an insulin secretagogue (ie sulfonylurea) it is best to talk to your healthcare provider about possibly lowering the dose of these medications to lower the risk of hypoglycemia.
  • Increasing heart rate
  • Worsening depression, behavior changes, or suicidality
  • Never share the Ozempic® pen with other people

SIDE EFFECTS

Many people experience no side effects. Some of the most common or potential side effects include:

  • Nausea
  • Constipation
  • Vomiting
  • Diarrhea
  • Abdominal Pain
  • Headache
  • Indigestion
  • Injection site reactions
  • Dizziness
  • Back pain
  • Increased Lipase or Amylase
  • Altered taste
  • Nasopharyngitis (common cold)
  • Passing Gas
  • Bloating
  • Belching
  • Gastroenteritis
  • Decreased appetite
  • Fatigue
  • Gastroesophageal reflux disease
  • Low blood sugar (hypoglycemia) in those with type II diabetes
  • Upset stomach

These symptoms often subside as your body adjusts to the medications. Please notify your provider if side effects persist. For a complete list of side effects, review the medication packaging inserts.

DRUG INTERACTIONS

As with other medications, Ozempic® can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of hypoglycemia is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Ozempic® delays gastric emptying and may impact the absorption of oral medications. If you are on thyroid hormone medication, prior to starting Ozempic®, please review the timing of taking your thyroid hormone medication with the doctor who prescribes it as it may need to be adjusted. The drug levels of medications with narrow therapeutic windows (ie warfarin) should be monitored closely while on Ozempic®.

Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.

To report suspected adverse reactions to Ozempic® contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

In case of emergencies, please call 911 or go to the nearest emergency room.

Naltrexone

WARNING

DO NOT take naltrexone if you are taking ANY opioids or opiate drugs or if you are dependent on opioids or using methadone or buprenorphine, or if you are in opioid withdrawal. If you take opioids/opiates right after stopping naltrexone you may be more sensitive to them (and require lower doses) - which poses a risk of overdose. Please talk to your provider before initiating any amount of opioids/opiates after stopping naltrexone. Do not take this medication if you have a sensitivity to it or any of its components.

Before using naltrexone, tell your healthcare provider about your medical history, especially if you have:

  • kidney disease
  • liver disease (as it may cause liver dysfunction or hepatitis)
  • depression/suicidality
  • current or recent (7-14 days) use of any type of opioid or opiate drugs

This drug may make you dizzy or drowsy or impair your judgment. Please do not drive, operate heavy machinery, or perform any hazardous task until the effects of naltrexone are known to you. For anyone taking diabetes medications, please have a discussion with your prescribing clinician prior to taking naltrexone as your diabetes medications may need to be adjusted as you lose weight. You should wear medical identification stating that you are taking this drug so that appropriate treatment can be given in a medical emergency.

Tell your healthcare provider right away if you experience severe stomach or abdominal pain changes in vision, eye pain, burning or swollen eyes, chest pain, confusion, discomfort while urinating or frequent urination, fever, hallucinations or seeing, hearing, or feeling things that are not there, itching, mental depression or other mood or mental changes or suicidality, ringing or buzzing in the ears, shortness of breath, swelling of the face, feet, or lower legs or weight gain.

DO NOT take naltrexone if you are planning to become pregnant or if pregnant or breastfeeding.

SIDE EFFECTS

Many people experience no side effects while taking naltrexone. Some of the most common side effects (but not extremely frequent) are:

  • fatigue or low energy
  • difficulty sleeping
  • nervousness and anxiety
  • headache
  • nausea or vomiting
  • joint and muscle pain
  • stomach cramps or pain

Additional side effects include:

  • loss of appetite
  • diarrhea or constipation
  • increased energy
  • increased thirst
  • dizziness
  • skin rash
  • sexual problems in males
  • chills
  • runny nose
  • irritability or feeling down

These symptoms may subside after the body adjusts to the medication.

DRUG INTERACTIONS

As with other medications, naltrexone can interact with certain prescription and non-prescription medications and herbal products, including dextromethorphan, diarrhea medication, disulfiram, opioid pain or cough relievers (such as codeine) and thioridazine.
Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.

To report suspected adverse reactions to naltrexone contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

In case of emergencies, please call 911 or go to the nearest emergency room.

Orlistat

WARNING

Do not use orlistat if you have had an organ transplant because the medicine interferes with the medicines used to prevent transplant rejection. There have been rare reports of liver injury in people taking orlistat.

Before using orlistat tell your healthcare provider about your medical history, especially if you have:

  • gallbladder problems
  • kidney stones
  • pancreatitis

Ask your healthcare provider before you use orlistat if you are taking any of the following prescription medications:

  • anticoagulants (blood thinning medicine)
  • amiodarone (heart medicine)
  • diabetes medicine
  • thyroid disease medicine
  • seizure medicine (for a seizure disorder)
  • antiretrovirals (HIV medicine)
  • taking any other weight loss products

You should not take orlistat if you are planning to become pregnant or if pregnant or breastfeeding. Do not use orlistat if you are not overweight or if you have been diagnosed with problems absorbing food. When using this medication, you should also take a multivitamin once a day at bedtime, and follow a well-balanced, reduced-calorie, low-fat diet. If you have any serious side effects, including, itching, yellow eyes or skin, dark urine, loss of appetite, severe or continuous abdominal pain, hives, vomiting, chest pain, rectal bleeding, constipation that lasts more than 7 days, difficulty swallowing or breathing, or you are taking medicine for seizures and your seizures happen more often or get worse, stop using the medication and talk to your healthcare provider.

SIDE EFFECTS

Many people experience no side effects while taking orlistat. Some of the most common side effects (but not extremely frequent) are:

  • diarrhea
  • oily stools or spotting
  • stomach discomfort
  • gas
  • more frequent bowel movements that may be hard to control

Additional side effects include:

  • loss of appetite
  • diarrhea or constipation
  • increased energy
  • increased thirst
  • dizziness
  • skin rash
  • sexual problems in males
  • chills
  • runny nose
  • irritability or feeling down

These symptoms may subside after the body adjusts to the medication.

DRUG INTERACTIONS

Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.

To report suspected adverse reactions, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

In case of emergencies, please call 911 or go to the nearest emergency room.

Semaglutide + B12

WARNING

Please contact your doctor ASAP and seek in-person care immediately if a side effect becomes problematic or you experience:

  • Severe nausea and/or vomiting resulting in dehydration -  it is important to stay well hydrated and drink plenty of fluids while on this medication
  • Kidney problems/kidney failure - vomiting, nausea, diarrhea can cause dehydration and kidney issues and make kidney problems worse in individuals who have pre-existing kidney conditions; may sometimes lead to the need for hemodialysis
  • Thyroid C-Cell Tumor: Trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath (see black box warning below)
  • Pancreatitis: Severe pain in your abdomen or back that will not go away
  • Acute gallbladder disease - Pain in the middle or right upper stomach, fever, white parts of your eyes turn yellow or skin turns yellow, nausea/vomiting. If gallstones or inflammation of the gallbladder is suspected further studies are needed.
  • Hepatitis/Elevated liver enzymes/Jaundice
  • Diabetic retinopathy problems: Changes in vision in those with type II diabetes, particularly vision problems may worsen in those with a history of diabetic retinopathy
  • Severe gastrointestinal disease - may cause gastrointestinal disease; do not use if you have a history of severe gastrointestinal disease
  • Signs of low blood sugar (for example, dizziness, weakness, shakiness, jitteriness, headache, anxiety/mood changes, rapid heartbeat, confusion, slurred speech, sweating, or lightheadedness)
  • While this is rare with GLP-1s, if it occurs, please seek in-person care immediately. If you have these symptoms, try having liquid or food containing sugar (around 15-20 grams) —drinking juice, having regular soda, or eating some hard candies right away, as this will help raise your blood sugar quickly. If taken with insulin or an insulin secretagogue (ie sulfonylurea) it is best to talk to your healthcare provider about possibly lowering the dose of these medications to lower the risk of hypoglycemia.
  • Increasing heart rate
  • Worsening depression, behavior changes, or suicidality
    Never share the semaglutide with other people

Note: The above statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

BLACK BOX WARNING:

GLP-1s are contraindicated in individuals with a history of medullary thyroid carcinoma, a family history of such, or in patients with multiple endocrine neoplasia syndrome type 2. Do not take them if you have ever had thyroid cancer. In studies with rodents, GLP-1s caused thyroid tumors, including thyroid cancer; it is not known if they will cause thyroid tumors or cancer in humans. Please notify your doctor ASAP if you develop trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.

If you experience a medical emergency, call 911 or go to the nearest emergency room.

Tell your healthcare provider about your medical history prior to taking semaglutide.

Avoid alcohol while taking this medication. If you’re taking diabetes medications, please discuss this with your prescribing doctor before starting semaglutide, as your diabetes medications may need to be adjusted as you lose weight.

Use adequate contraception while taking this medication. Do not take this medication if pregnant, trying to get pregnant or breastfeeding. If you plan to become pregnant, this medication needs to be stopped at least 2 months before trying. This medication may cause fetal harm.

Notify your doctor if you have kidney, liver, or pancreas problems.

Stop using semaglutide and call your healthcare provider immediately if you have severe stomach or abdomen pain that will not go away, with or without vomiting.

Stop using semaglutide and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat.

Serious hypersensitivity reactions (e.g., anaphylaxis and angioedema) have been reported. Discontinue semaglutide if suspected and promptly seek medical advice.

Ozempic®

BLACK BOX WARNING:

GLP-1s are contraindicated in individuals with a history of medullary thyroid carcinoma, a family history of such, or in patients with multiple endocrine neoplasia syndrome type 2. Do not take them if you have ever had thyroid cancer. In studies with rodents, GLP-1s caused thyroid tumors, including thyroid cancer; it is not known if they will cause thyroid tumors or cancer in humans. Please notify your doctor ASAP if you develop trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.

If you experience a medical emergency, call 911 or go to the nearest emergency room.

Tell your healthcare provider about your medical history prior to taking Ozempic®.

Avoid alcohol while taking this medication. If you’re taking diabetes medications, please discuss this with your prescribing doctor before starting Ozempic®, as your diabetes medications may need to be adjusted as you lose weight.

Use adequate contraception while taking this medication. Do not take this medication if pregnant, trying to get pregnant or breastfeeding. If you plan to become pregnant, this medication needs to be stopped at least 2 months before trying. This medication may cause fetal harm.

Notify your doctor if you have kidney, liver, or pancreas problems.

Stop using Ozempic® and call your healthcare provider immediately if you have severe stomach or abdomen pain that will not go away, with or without vomiting.

Stop using Ozempic® and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat.

Serious hypersensitivity reactions (e.g., anaphylaxis and angioedema) have been reported. Discontinue Ozempic® if suspected and promptly seek medical advice.

WARNING

Please contact your doctor ASAP and seek in-person care immediately if a side effect becomes problematic or you experience:

  • Severe nausea and/or vomiting resulting in dehydration-  it is important to stay well hydrated and drink plenty of fluids while on this medication
  • Kidney problems/kidney failure - vomiting, nausea, diarrhea can cause dehydration and kidney issues and make kidney problems worse in individuals who have pre-existing kidney conditions; may sometimes lead to the need for hemodialysis
  • Thyroid C-Cell Tumor: Trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath (see black box warning below)
  • Pancreatitis: Severe pain in your abdomen or back that will not go away
  • Acute gallbladder disease - Pain in the middle or right upper stomach, fever, white parts of your eyes turn yellow or skin turns yellow, nausea/vomiting. If gallstones or inflammation of the gallbladder is suspected further studies are needed.
  • Hepatitis/Elevated liver enzymes/Jaundice
  • Diabetic retinopathy problems: Changes in vision in those with type II diabetes, particularly vision problems may worsen in those with a history of diabetic retinopathy
  • Severe gastrointestinal disease - may cause gastrointestinal disease; do not use if you have a history of severe gastrointestinal disease
  • Signs of low blood sugar (for example, dizziness, weakness, shakiness, jitteriness, headache, anxiety/mood changes, rapid heartbeat, confusion, slurred speech, sweating, or lightheadedness). While this is rare with GLP-1s, if it occurs, please seek in-person care immediately. If you have these symptoms, try having liquid or food containing sugar (around 15-20 grams) —drinking juice, having regular soda, or eating some hard candies right away, as this will help raise your blood sugar quickly. If taken with insulin or an insulin secretagogue (ie sulfonylurea) it is best to talk to your healthcare provider about possibly lowering the dose of these medications to lower the risk of hypoglycemia.
  • Increasing heart rate
  • Worsening depression, behavior changes, or suicidality
  • Never share the Ozempic® pen with other people

Side Effects

Many people experience no side effects. Some of the most common or potential side effects include:

  • Nausea
  • Constipation
  • Vomiting
  • Diarrhea
  • Abdominal Pain
  • Headache
  • Indigestion
  • Injection site reactions
  • Dizziness
  • Back pain
  • Increased Lipase or Amylase
  • Altered taste
  • Nasopharyngitis (common cold)
  • Passing Gas
  • Bloating
  • Belching
  • Gastroenteritis
  • Decreased appetite
  • Fatigue
  • Gastroesophageal reflux disease
  • Low blood sugar (hypoglycemia) in those with type II diabetes
  • Upset stomach

These symptoms often subside as your body adjusts to the medications. Please notify your provider if side effects persist. For a complete list of side effects, review the medication packaging inserts.

Drug Interactions

As with other medications, Ozempic® can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of hypoglycemia is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Ozempic® delays gastric emptying and may impact the absorption of oral medications. If you are on thyroid hormone medication, prior to starting Ozempic®, please review the timing of taking your thyroid hormone medication with the doctor who prescribes it as it may need to be adjusted. The drug levels of medications with narrow therapeutic windows (ie warfarin) should be monitored closely while on Ozempic®.

Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.

To report suspected adverse reactions to Ozempic® contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

In case of emergencies, please call 911 or go to the nearest emergency room.

Wegovy®

BLACK BOX WARNING:

GLP-1s are contraindicated in individuals with a history of medullary thyroid carcinoma, a family history of such, or in patients with multiple endocrine neoplasia syndrome type 2. Do not take them if you have ever had thyroid cancer. In studies with rodents, GLP-1s caused thyroid tumors, including thyroid cancer; it is not known if they will cause thyroid tumors or cancer in humans. Please notify your doctor ASAP if you develop trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.

If you experience a medical emergency, call 911 or go to the nearest emergency room.

Tell your healthcare provider about your medical history prior to taking Wegovy®.

Avoid alcohol while taking this medication. If you’re taking diabetes medications, please discuss this with your prescribing doctor before starting Wegovy®, as your diabetes medications may need to be adjusted as you lose weight.

Use adequate contraception while taking this medication. Do not take this medication if pregnant, trying to get pregnant or breastfeeding. If you plan to become pregnant, this medication needs to be stopped at least 2 months before trying. This medication may cause fetal harm.

Notify your doctor if you have kidney, liver, or pancreas problems.

Stop using Wegovy® and call your healthcare provider immediately if you have severe stomach or abdomen pain that will not go away, with or without vomiting.

Stop using Wegovy® and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat.

Serious hypersensitivity reactions (e.g., anaphylaxis and angioedema) have been reported. Discontinue Wegovy® if suspected and promptly seek medical advice.

WARNING

Please contact your doctor ASAP and seek in-person care immediately if a side effect becomes problematic or you experience:

  • Severe nausea and/or vomiting resulting in dehydration-  it is important to stay well hydrated and drink plenty of fluids while on this medication
  • Kidney problems/kidney failure - vomiting, nausea, diarrhea can cause dehydration and kidney issues and make kidney problems worse in individuals who have pre-existing kidney conditions; may sometimes lead to the need for hemodialysis
  • Thyroid C-Cell Tumor: Trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath (see black box warning below)
  • Pancreatitis: Severe pain in your abdomen or back that will not go away
  • Acute gallbladder disease - Pain in the middle or right upper stomach, fever, white parts of your eyes turn yellow or skin turns yellow, nausea/vomiting. If gallstones or inflammation of the gallbladder is suspected further studies are needed.
  • Hepatitis/Elevated liver enzymes/Jaundice
  • -Diabetic retinopathy problems: Changes in vision in those with type II diabetes, particularly vision problems may worsen in those with a history of diabetic retinopathy
  • Severe gastrointestinal disease - may cause gastrointestinal disease; do not use if you have a history of severe gastrointestinal disease
  • Signs of low blood sugar (for example, dizziness, weakness, shakiness, jitteriness, headache, anxiety/mood changes, rapid heartbeat, confusion, slurred speech, sweating, or lightheadedness). While this is rare with GLP-1s, if it occurs, please seek in-person care immediately. If you have these symptoms, try having liquid or food containing sugar (around 15-20 grams) —drinking juice, having regular soda, or eating some hard candies right away, as this will help raise your blood sugar quickly. If taken with insulin or an insulin secretagogue (ie sulfonylurea) it is best to talk to your healthcare provider about possibly lowering the dose of these medications to lower the risk of hypoglycemia.
  • Increasing heart rate
  • Worsening depression, behavior changes, or suicidality
  • Never share the Wegovy® pen with other people

Side Effects

Many people experience no side effects. Some of the most common or potential side effects include:

  • Nausea
  • Constipation
  • Vomiting
  • Diarrhea
  • Abdominal Pain
  • Headache
  • Indigestion
  • Injection site reactions
  • Dizziness
  • Back pain
  • Increased Lipase or Amylase
  • Altered taste
  • Nasopharyngitis (common cold)
  • Passing Gas
  • Bloating
  • Belching
  • Gastroenteritis
  • Decreased appetite
  • Fatigue
  • Gastroesophageal reflux disease
  • Low blood sugar (hypoglycemia) in those with type II diabetes
  • Upset stomach

These symptoms often subside as your body adjusts to the medications. Please notify your provider if side effects persist. For a complete list of side effects, review the medication packaging inserts.

Drug Interactions

As with other medications, Wegovy® can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of hypoglycemia is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Wegovy® delays gastric emptying and may impact the absorption of oral medications. If you are on thyroid hormone medication, prior to starting Wegovy®, please review the timing of taking your thyroid hormone medication with the doctor who prescribes it as it may need to be adjusted. The drug levels of medications with narrow therapeutic windows (ie warfarin) should be monitored closely while on Wegovy®.

Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.

To report suspected adverse reactions to Wegovy® contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

In case of emergencies, please call 911 or go to the nearest emergency room.

Compounded Semaglutide

*Compounded medications may be prescribed by physicians but have not been FDA regulated for safety, effectiveness, or quality. FDA-approved medicines containing semaglutide are available.

WARNING

Please contact your doctor ASAP and seek in-person care immediately if a side effect becomes problematic or you experience:

  • Severe nausea and/or vomiting resulting in dehydration—it is important to stay well hydrated and drink plenty of fluids while on this medication
    Kidney problems/kidney failure - vomiting, nausea, diarrhea can cause dehydration and kidney issues and make kidney problems worse in individuals who have pre-existing kidney conditions; may sometimes lead to the need for hemodialysis
  • Thyroid C-Cell Tumor: Trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath (see black box warning below)
  • Pancreatitis: Severe pain in your abdomen or back that will not go away
  • Acute gallbladder disease - Pain in the middle or right upper stomach, fever, white parts of your eyes turn yellow or skin turns yellow, nausea/vomiting. If gallstones or inflammation of the gallbladder is suspected further studies are needed.
  • Hepatitis/Elevated liver enzymes/Jaundice
  • Diabetic retinopathy problems: Changes in vision in those with type II diabetes, particularly vision problems may worsen in those with a history of diabetic retinopathy
  • Severe gastrointestinal disease - may cause gastrointestinal disease; do not use if you have a history of severe gastrointestinal disease
  • Signs of low blood sugar (for example, dizziness, weakness, shakiness, jitteriness, headache, anxiety/mood changes, rapid heartbeat, confusion, slurred speech, sweating, or lightheadedness). While this is rare with GLP-1s, if it occurs, please seek in-person care immediately. If you have these symptoms, try having liquid or food containing sugar (around 15-20 grams) —drinking juice, having regular soda, or eating some hard candies right away, as this will help raise your blood sugar quickly. If taken with insulin or an insulin secretagogue (i.e. sulfonylurea such as Glipizide, glimepiride, and glyburide) it is best to talk to your healthcare provider about possibly lowering the dose of these medications to lower the risk of hypoglycemia.
  • Increasing heart rate
  • Worsening depression, behavior changes, or suicidality

Never share the semaglutide with other people

Drug Interactions

As with other medications, compounded semaglutide can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of hypoglycemia is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Compounded semaglutide delays gastric emptying and may impact the absorption of oral medications. If you are on papillary hormone medication, prior to starting compounded semaglutide, please review the timing of taking your papillary hormone medication with the doctor who prescribes it as it may need to be adjusted. The drug levels of medications with narrow therapeutic windows (ie warfarin) should be monitored closely while on compounded semaglutide.

Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.

To report suspected adverse reactions to compounded semaglutide, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

In case of emergencies, please call 911 or go to the nearest emergency room.

Note: The above statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

BLACK BOX WARNING

GLP-1s are contraindicated in individuals with a history of medullary thyroid carcinoma, a family history of such, or in patients with multiple endocrine neoplasia syndrome type 2. Do not take them if you have ever had thyroid cancer. In studies with rodents, GLP-1s caused thyroid tumors, including thyroid cancer; it is not known if they will cause thyroid tumors or cancer in humans. Please notify your doctor ASAP if you develop trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.

If you experience a medical emergency, call 911 or go to the nearest emergency room.

Tell your healthcare provider about your medical history prior to taking semaglutide.

Avoid alcohol while taking this medication. If you’re taking diabetes medications, please discuss this with your prescribing doctor before starting semaglutide, as your diabetes medications may need to be adjusted as you lose weight.

Use adequate contraception while taking this medication. Do not take this medication if pregnant, trying to get pregnant or breastfeeding. If you plan to become pregnant, this medication needs to be stopped at least 2 months before trying. This medication may cause fetal harm.

Notify your doctor if you have kidney, liver, or pancreas problems.

Stop using semaglutide and call your healthcare provider immediately if you have severe stomach or abdomen pain that will not go away, with or without vomiting.

Stop using semaglutide and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat.

Serious hypersensitivity reactions (e.g., anaphylaxis and angioedema) have been reported. Discontinue semaglutide if suspected and promptly seek medical advice.